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1 Introduction 
For many centuries people were trying to understand the basic mechanisms of 
nature and to use them for curing of diseases. Nowadays nanotechnology is one 
of the modern and promising areas for solving a huge variety of problems in 
healthcare and in medicine as well as in technology. Nanotechnology works 
with objects of size up to 1 µm, thus manipulating on a dimension much smaller 
than living cells. It is already widely used in medicine and molecular biology, 
e.g. in diagnostics, drug delivery, cell sorting, production of stable cell lines and 
transgenic animals. 
One of the most advantageous areas is the application of nanoparticles as 
carriers of drugs and nucleic acids into cells thus acquiring new cell properties: 
synthesis of a failing or a completely new protein, inhibition of gene expression,  
breaking of the immune tolerance against viral or bacterial antigens. However, 
although this seems quite easy, scientists still face many challenges. Some 
carriers are very effective but immunogenic and cancerogenic, others are not so 
toxic but show very low efficiency. So it is always a problem of choice, of 
finding an optimal balance between drawbacks and advantages. 
We were interested in the synthesis and application of non-toxic and potentially 
very effective nanoparticles. Thus, we chose calcium phosphate as a core 
material for our gene delivery system.  In this study we produced calcium 
phosphate nanoparticles functionalized with nucleic acids (DNA and RNA)   
and tested them on cell cultures. The first chapter deals with the synthesis of 
nanoparticles with different additives and under different conditions in order to 
achieve smaller nanoparticles able to bind DNA.  
However, the toxicity needed further investigation. As it is well known, the 
intracellular calcium level is quite low and its increase can disturb many 
processes, e.g. muscle contraction or intracellular signaling pathways, thus 
causing cell death. So we explicitly studied the changes of the intracellular 
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calcium level via application of 
45
Ca
2+
 and the marker of ionic calcium Fura-2. 
We also analyzed the vitality of the cells transfected by different methods. 
The next step was to protect the DNA against intracellular cleavage by 
nucleases; therefore we synthesized multi-shell nanoparticles and functionalized 
them with oligonucleotides to achieve an effective gene silencing. By using 
oligonucleotides, we could also stimulate immune cells and break the tolerance 
against previously undetectable antigens.  
Our next step was to localize the application of nanoparticles. Therefore we 
coated metal surfaces by electrophoresis, achieving not systemic but local 
transfection. This could possibly be used for bone defects healing, stimulating 
bone growth by covering the implants. 
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2 Theoretical background 
2.1 Nucleic acids 
Nucleic acids are organic macromolecules maintaining the storage and transfer 
of hereditary information in living cells and viruses. The nucleic acids can be 
divided into two main groups depending on the type of the sugar: 
desoxyribonucleic acids (DNA) and ribonucleic acids (RNA).  
DNA contains information about the aminoacidic sequences of the proteins in 
all living cells and most viruses and thereby serves for long-term information 
storage.   
RNA works as a transfer molecule, delivering the information from the nuclear 
DNA to the place of protein synthesis, or delivering single amino acids to the 
ribosomes providing the short-term information storage.  
 
2.1.1 Chemical structure of desoxyribonucleic acid (DNA) 
DNA is a polymeric biomolecule consisting of monomers called nucleotides. 
Each nucleotide consists of a pentose (desoxyribose), a phosphoric acid residue 
and a nucleic base. The DNA molecule forms a double helix.
[1-3]
 In such a helix, 
the sugar and the nucleic bases are turned inward.
[4]
 The bases hold the chains 
together due to the formation of two or three hydrogen bonds, depending on the 
type of the base. 
 
 
Figure 2.1.1.1: Sugar and nucleic bases in DNA. 
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The nucleic bases are paired not randomly, but in a predefined order. There are 
two types of bases: purines (adenine and guanine) and pyrimidines (thymine and 
cytosine) as shown in Figure 2.1.1.1.
[5-7]
  According to Chargaff‟s rules, in DNA 
thymine always binds to adenine, guanine to cytosine and vice versa. The bases 
are paired due to the hydrogen bonds to form Watson-Crick base pairs.
[1]
 
Monomers of the nucleic acid are used in the cell not only as a structural unit of 
DNA, but also in some cofactors and as a signaling or as an energy-efficient 
molecule.
[8,9]
 
Due to a great amount of information contained in DNA, it is a very large 
molecule; therefore it must be packed inside the cell.  In living organisms DNA 
is present mostly in two forms: As a circular molecule in prokaryotic cells and 
as chromosomes in eukaryotes.  Because the interest of this work is human gene 
therapy, we will focus on the structure of the eukaryotic DNA. 
First, the chains of DNA form a double helix. Then this helix is wrapped around 
special packaging proteins (histones), moulding a simple circular unit called 
nucleosome.
[3]
 The nucleosome beads form compact fibrils with a diameter of 
about 100 Å. These fibrils form a helix where one turn comprises about 3-6 
nucleosomes. Afterwards this complex helix is organized in loop-structures of 
thick fibrils. The ends of the loops are fixed on a chromosome backbone. The 
following condensation can proceed due to the spiralization of loops and 
backbone structures, and the diameter of the final chromosome is about 2 μm. 
 
2.1.2 Chemical structure of ribonucleic acid (RNA) 
The RNA nucleotides have structural differences comparing to DNA. Here 
ribose replaces desoxyribose as sugar and uracil replaces thymine.
[10]
 RNA is 
transcribed on the DNA matrix by enzymes and must be further processed. RNA 
serves as the template for translation of the genetic information into the proteins 
and transferring the single amino acids to the ribosome to form proteins.  
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RNA consists of four different bases: Adenine, guanine, cytosine, and uracil. 
The first three are the same as those of DNA, but uracil replaces thymine.
[11]
 
 
 
Figure 2.1.2.1: Chemical structure of ribose and uracil. 
 
RNA usually is a single-stranded molecule and has a short nucleotide chain. 
Double-stranded RNA molecules were found only in viruses. There are several 
different types of RNA: mRNA, tRNA, rRNA.
[10]
 
Messenger RNA (mRNA) carries information from DNA to the ribosome where 
protein synthesis occurs. mRNA is transcribed from DNA, proceeded and 
transferred from the nucleus into the cytoplasm, where it bounds to the 
ribosomes.  
Transfer RNA (tRNA) is a small RNA containing about 74-93 nucleotides that 
transports a specific amino acid to a place of protein synthesis. It has binding 
sites for amino acids on one side and an anticodon region that binds to a specific 
sequence on the mRNA chain on the other side. 
Ribosomal RNA (rRNA) is a structural component of the ribosomes. 
The other types of RNA are so-called non-coding RNA or "RNA genes" 
(sometimes referred to as small RNA) which encode RNA that is not translated 
into the proteins. These are siRNAs (small interfering RNA), miRNAs 
(microRNA) and shRNAs (short hairpin RNA). In the eukaryotes they also act 
as triggers to initiate the process of RNA interference and to regulate gene 
expression.
[12-15]
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2.1.3 Biological role of nucleic acids 
The central dogma of molecular biology
[12,16]
 postulates that all genetic 
information is realized in the same definite way: 
DNA → RNA → protein 
All inherited and individual information about the organism is stored in the 
genome. In eukaryotic cells the genome is present mainly in the nucleus. All 
processes of transcription and replication occur under the close regulation of 
enzymes and packaging proteins.  
The sequences of nucleic bases in DNA encode the sequences of amino acids in 
proteins. In such a way DNA encodes all the mechanisms of development of 
every organism.  Each amino acid is coded by three nucleotides forming triplet 
codons. There are 4
3
=64 possible combinations of the nucleotides. The genetic 
code is redundant, i.e. each amino acid is encoded by more than one codon. This 
characteristic of the genetic code makes it more stable to the changes induced by 
point mutations of DNA. 
 
2.2 Mechanism of RNA interference 
The mechanism of RNA interference (or RNA silencing) was first described by 
Fire and Mello in the late 1990s.
[17]
 They found that the interaction between 
mRNAs and specific double-stranded RNAs can lead to the cleavage of the 
initial mRNA. So, RNA interference (RNAi) is a process of sequence-specific 
post-transcriptional gene silencing initiated by double-stranded siRNA (so-
called small interfering RNA). In many organisms the RNA silencing 
mechanism is a part of the immune response against RNA-containing viruses.
[18]
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Figure 2.2.1: Schematic representation of gene silencing mechanism. 
 
Different types of double-stranded RNAs from Arabidopsis thaliana, 
Trypanosomes, Drosophila, C. elegans and different mammals were 
investigated,
[12,14]
 showing the differences in some steps of gene silencing, but 
the principle of the process remains unchanged. In mammals, the long siRNA-
precursor is processed inside the cell by the specific RNase III-type 
endonuclease (called Dicer) into small  functional fragments of siRNA duplexes, 
which are around  21 bp, of which 19 nucleotides form a helix and 2 nucleotides 
on each of 3´ ends are unpaired (Figures 2.2.1 and 2.2.2). The point is that only 
short RNA duplexes can be used without evoking of a nonspecific immune 
response by interferons, which usually leads to shutdown of protein synthesis 
and global RNA degradation. 
[12,13,19]
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Figure 2.2.2: Schema of gene silencing by siRNA: Double stranded RNA, 
consisting of sense and anti-sense strands, is cleaved by Dicer to produce siRNA 
duplexes. These siRNAs will incorporate into a RISC complex and will be 
unwound by its helicase activity. Then the antisense strand of siRNA hybridizes 
to mRNA which afterwards will be cleaved. 
 
 
The following maturation of siRNA includes the formation of the complex 
between the RNA duplex and the proteins, including proteins of the Argonaute 
family (Ago2) and subsequent transient association with Dicer. These 
complexes of ribonucleoprotein particles are afterwards rearranged into the so-
called RNA-induced silencing complex (RISC) with different molecular mass, 
e.g. for humans it is between 130 and 160 kDa.
[20,21]
 The further unwinding of 
the siRNA strands results in the formation of activated RISCs. These activated 
RISCs then bind to complementary or near complementary target mRNA 
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molecules leading to their cleavage. That leads to the inhibition of protein 
synthesis – gene silencing. 
shRNA (short hairpin) is one of the predecessors of siRNA. shRNA is called so 
due to its structure: Sense and antisense strands are bound together via small ~9-
nt loop. It is usually introduced into the cell as a vector, which is then 
transcribed by cellular RNA polymerase III to shRNA which is then cleaved to 
siRNA. This process may give outstanding possibilities for the inherited 
inhibition of proteins. 
Nowadays the application of dsRNA as a direct intervention for the treatment of 
human diseases remains one of the great challenges. RNAi is investigated first 
of all as a potential immune-type surveillance mechanism against viruses for 
mammals.
[22]
 Previously, the above described effect was already shown to take 
place in the cells of some invertebrates, such as C. elegans and Drosophila.
[12]
 
[23]
 This technology is also widely applied for pathway and gene functions 
analysis,
[24,25]
 and for identification and validation of new drug targets for many 
diseases including cancer.
[26]
 
 
2.3 Oligonucleotides for the maturation of dendritic cells 
Another function of nucleic acids is an indirect influence on the cell 
development not through the control of protein synthesis but through specific 
receptor-mediated recognition and activation of the signaling mechanisms. 
Some oligonucleotides are known to be present also in microbial DNA, thus 
recognized by the immune system and leading to activation and maturation of B- 
cells and dendritic cells.
[27]
  This activation leads to immune response against 
microbial antigens.  
One of the immunostimulatory oligonucleotides are so-called CpG fragments 
with an increased density of C and G nucleotides.
[27,28]
 The other type of such 
stimulatory nucleic acids are poly(inosinic acid)-poly(cytidylic acid).
[29]
 They 
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both are known to be able to mimic the ability of microbial DNA to activate the 
innate immune system.
[27,28,30-33]
 They induce the maturation of dendritic 
cells,
[34,35]
 thus breaking the tolerance and activating the immune system against 
previously undetectable antigens.
[36]
 These responses can be detected via the 
secretion of specific proteins by cells, e.g. interleukins (IL-6 and 12), IFN-α 
(interferon), CD-80 and CD-86.
[28,29,37]
 
 
2.4 Transfection 
The method of introduction of foreign nucleic acids (DNA or RNA) into 
eukaryotic cells is called transfection. Such an introduction leads to the 
regulation of the desirable protein synthesis, e.g. production of a failing protein, 
blocking of the overexpression, acquiring new cell properties or replacement of 
a defect protein. Thus, the application of the technique allows the production of 
new cell lines as well as the potential treatment of a wide variety of diseases. 
However, during the transfection the nucleic acid must overcome many barriers 
(cell and nuclear membranes) and also escape the degradation by the 
cytoplasmatic endonucleases.
[38,39]
 Therefore, the development of an efficient 
transfection technique meets many difficulties and among them the low 
efficiency of some methods and high toxicity of others. That is why the 
development of efficient and safe transfection methods is a great challenge in 
gene therapy.  
To introduce the nucleic acid into the cell, special carriers are usually needed. 
Transfection systems may be divided into two main groups: viral and non-viral 
techniques.
[40]
 
1. Viral gene delivery systems.  
Virus-based gene delivery systems are the most effective transfection technique. 
They are based on viral ability to infect cells. These techniques are applied for 
more than 50 years using adenoviruses,
[36,41-43]
 retroviruses,
[44-46]
 and other 
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viruses.
[31,47,48]
 However, these methods have potential disadvantages, e.g. 
immunogenicity, inflammatory response, and carcinogenicity, thus promoting 
the development of alternative delivery systems. Moreover, although viral 
particles can easily penetrate into the cell, even impaired viruses remain 
potentially dangerous because of the threat of the recreation of the highly 
infectious wild-type viruses.
[40]
 
Thus, different non-viral transfection techniques were developed and tested 
although they have a much lower efficiency than virus-based systems. 
2. Nonviral gene delivery systems can be divided into two subgroups: physical 
and chemical methods.  
- Physical methods are microinjection
[49,50]
 and electroporation.
[51-53]
 However, 
by microinjection one can transfect only a single cell at a time, but not many, i.e. 
this method cannot be used for large numbers of cells and for in vivo 
experiments. As for the electroporation, in order to achieve the successful 
transfection it requires an optimization of many parameters for every cell type, 
such as the voltage or the length of the pulse.  
- The chemical methods of nucleic acid delivery include different agents able to 
form a complex with DNA and transport it inside the cell.  These carriers can be 
divided into three groups: cationic compounds, recombinant proteins and 
inorganic nanoparticles. 
Cationic compounds include a variety of cationic lipids,
[54-62]
 and polymers, e.g. 
poly(ethylene imine),
[63]
 poly(methacrylic acid), poly(vinylpyrrolidone),
[64]
 and 
poly(lactic-co-glycolic acid).
[65]
 The cationic lipids decrease the negative charge 
of the DNA, thus facilitating its transport through a negatively charged cell 
membrane. 
Recombinant proteins are used as carriers and also as nuclear localization 
sequences. They may include polylysine or polyarginine segments for sufficient 
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charge. Moreover, protamines or histones may bind DNA to protect it from the 
degradation by nucleases.
[66-70]
 
Inorganic nanoparticles consist of different elements: gold,
[71-74]
 silver,
[75,76]
 
magnetite,
[77-79]
 silica,
[80]
 carbon,
[81]
 manganese phosphate
[82]
 and calcium 
phosphate. The great advantage of the calcium phosphate transfection method is 
that it provides a higher biocompatibility than other types of nanoparticles.  
The standard calcium phosphate transfection method was introduced by Graham 
and van der Eb in early 1970s.
[83]
 Here calcium phosphate spontaneously forms 
complexes with DNA in situ. Usually these complexes consist of DNA 
backbone and “beards” of calcium phosphate crystals on in, and calcium 
phosphate particles with inorganic core and nucleic acid as a shell. But such a 
method has definite drawbacks such as polydispersity of the particles, little 
control of the experimentalist over their size and morphology, non-physiological 
pH of the dispersion and short storage time.  
Thus, in spite of the fact that the inorganic nanoparticles cannot compete with 
viral methods or liposomes in high transfection efficiency, they have often a low 
toxicity, easy and low-cost preparation and good storage stability.  
 
2.5 Calcium phosphate nanoparticles as carriers of nucleic acids 
Calcium and phosphorus are very important inorganic components of biological 
hard tissues, e.g. bones and teeth.
[84]
 They are also included in the regulation of 
many processes, such as the transfer of intracellular signals (where calcium ions 
act as mediators) or maintenance of salt balance of organism.  
As minerals, calcium phosphates form large crystals, but their biological 
formation often leads to nanocrystals because it takes place under mild 
conditions.
[85]
 Also these calcium phosphates often include different additives 
such as sodium, magnesium or carbonate. An important parameter for the 
formation of different calcium phosphates is also the molar Ca/P ratio and 
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solubility. Most types of calcium phosphates are only partially soluble in water 
or insoluble at all, but they can all be dissolved in acids.
[84]
  
Thus, calcium phosphate possesses very important properties for the application 
to living objects: It is biocompatible due to its chemical nature and thus 
biodegradable.  
As carriers of nucleic acids, calcium phosphate nanoparticles have been widely 
used for more than 35 years. The precipitation occurs in situ and includes a 
subsequent mixing of calcium chloride solution, DNA and phosphate-buffered 
saline solution. This results in the formation of polydisperse nano- and 
microparticles of calcium phosphate and DNA.
[42,83,86-90]
 This dispersion is added 
to a cell suspension, and the nanoparticles are taken up by cells. 
[91]
 
The interaction between calcium phosphate and nucleic acid occurs presumably 
due to the affinity of calcium to the phosphate backbone in nucleic acids (Figure 
2.5.1),
[91-94]
 thus making the nucleotide sequence of the nucleic acid 
unimportant, but taking into account its length.
[95]
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Figure 2.5.1: Schematic model of the interaction between the surface of a 
calcium phosphate nanoparticle and a nucleic acid.
[91]
 
 
To have more control over the precipitation of calcium phosphate and, therefore, 
over the particle morphology and size, many ways of synthesis were developed.   
Bisht et al. prepared calcium phosphate nanoparticles in microemulsion, thus 
precipitation takes place only in an aqueous core of the microemulsion 
droplets.
[96]
 These particles had a size of 30-40 nm but rapidly aggregated with 
time. Fu and co-workers used calcium phosphate/DNA precipitates together 
with porous collagen spheres to transfect different cell lines.
[97]
 These particles 
had a size of 50-200 nm and could effectively transfect cells. They could be 
stored for approx. 5 days, but with a loss of efficiency. Olton et al. prepared 
monodisperse calcium phosphate nanoparticles with a typical diameter of 25-
50 nm by precipitation in the presence of DNA and found a most efficient 
transfection.
[98]
 Sokolova et al. prepared calcium phosphate nanoparticles by 
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rapid precipitation of calcium and phosphate, followed by an immediate 
functionalization with DNA
[99]
 or oligonucleotides.
[95]
 These particles typically 
have a size of 80 nm and form stable colloidal solutions. To protect DNA 
against degradation in the cytoplasm by endonucleases the additional shells of 
calcium and phosphate were used to encapsulate DNA and to protect it on its 
way to the nucleus.
[100]
 
 
2.6 Colloid stability and DLVO theory 
A colloid is a system which consists of a dispersed phase distributed throughout 
a dispersion medium.
[101,102]
 The dimension of the disperse phase lies in the 
range of 1 nm to 1 µm. The most important properties of colloidal systems are 
the following:  
- Large ratio of the specific surface area to the volume of the dispersed particles; 
- Particle-particle interactions; 
- Volume effects compete with interfacial effects; 
- Adsorption of charged molecules on the surface. 
The colloid as well as the dispersant may be present in solid, liquid or gaseous 
form. The examples of colloidal systems are smoke, milk or glass.
[101,103,104]
 
The particles in a colloid are almost always electrically charged. This charge on 
the particle is balanced by the opposite charge in the surrounding fluid. Ions are 
adsorbed on colloidal particles, where they form the partly rigid, partly diffuse 
electrostatic double layer, leading to the so-called zeta potential, i.e. the 
difference in electrical potential between the dense layer of ions surrounding the 
particle and the bulk of the suspended fluid.
[105]
 
A colloidal dispersion may be stable or unstable towards aggregation. This will 
depend on the balance of the repulsive and attractive forces that exist between 
the particles. The DLVO theory (developed by Derjaguin, Landau, Verwey and 
Overbeek) states that the stability of a particle in solution depends on the total 
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interaction energy, which is the sum of the attractive van der Waals force and 
the repulsive force that arise when the diffuse double layers around the two 
particles overlap .
[102]
 
Theoretically, monodisperse colloidal systems should not aggregate. However, it 
is very difficult to prepare really monodisperse colloids.  
There are two general mechanisms for the stabilization of colloids: electrostatic 
repulsion between the electrical double layer and steric stabilization. The 
electrostatic stabilization occurs due to ions or charged molecules adsorbed on 
the particle surface as discussed above.  
The steric stabilizing mechanism includes the adsorption of protective agents 
(often polymeric) on the particle surface. Such molecules do not have to carry an 
electrical charge but must have a relatively low solubility in the dispersion 
medium and a high tendency to adsorb onto the particle surface which improves 
the stability of the colloid by the imposition of a barrier to a close particle 
approach. 
In our case the nucleic acids lead to both ways of stabilization: The DNA 
molecule gives steric stabilization and simultaneously provides electrostatic 
stability due to the negatively charged phosphate backbone.
[91]
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3 Materials and Methods 
3.1 Applied materials for cell culture experiments 
3.1.1 Cell culture solutions/antibiotics  
DMEM PAA 
FCS PAA, Biochrom 
Glutamine Gibco BRL/Invitrogen 
HEPES Biomol 
Penicillin/Streptomycin Gibco BRL/Invitrogen, PAA 
RPMI 1640 PAA 
L15 PAA 
Trypsine Gibco BRL/Invitrogen 
Geneticin (G418) Gibco BRL 
Propidium iodide Fluka 
DAPI Fluka 
Fura-2AM Invitrogen 
MTT Sigma 
DMSO JT Baker 
BM Cyclin PAA 
 
3.1.2 Chemicals  
Ampicillin Biomol 
Ethanol JT Baker 
Yeast extract Roth 
Pepton hydrolysate Roth 
SDS Biomol 
NaCl JT Baker 
Scintillation liquid Rotiszint eco Plus for hydrophilic 
samples, Carl Roth 
Poly-L-ornithine Sigma 
Triton X 100 AppliChem 
PMSF Acros 
Paraformaldehyde Janssen Chimika 
 
3.1.3 Instruments  
Incubator Heraeus 
Microscopes Olympus IX51 
Olympus IX 81 
Olympus CK 2 
Laminar flow hood Heraeus  
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Thermomixer Eppendorf  
Centrifuges Eppendorf 5415C (Minifuge) 
Heraeus Megafuge 1.0R  
Sorvall Superspeed RC2-B 
ELISA-Reader SLT Labinstruments 
Liquid Scintillation Analyzer Tri-Carb 2800TR, Perkin Elmer 
Vortex Vortex 2 Genie, Scientific Industries 
Shaker Certomat
® 
H 
Photometer UV 1202, Shimadzu 
Flow cytometer FACSCalibur™, BD-Bioscience 
CyFlow
® 
SL, Partec  
 
3.1.4 Applied consumables und kits 
Nucleobond
®
 PC 10000 plasmid 
DNA purification kit (endotoxin-
free) 
Macherey-Nagel 
 
QIAGEN Plasmid Maxi Kit Qiagen 
Bio-Rad DC Protein Assay Bio-Rad Laboratories 
Multiwell plates (24-, 6-wells) TPP 
Polyfect
®
 Qiagen 
Flasks 75 cm
3
 Nunc, TPP 
35 mm glass-bottom dishes MatTek Corporation 
35 mm dishes Nunc 
 
3.2 Molecular-biological methods  
3.2.1 Preparation of plasmid DNA from bacterial culture  
All work with the intact bacteria was carried out under semi-sterile conditions 
with autoclaved instruments and solutions. 
The preparation of the plasmid DNA for the transfection of the eukaryotic cells 
was performed with a NucleoBond
®
 PC 10000 EF kit and a Qiagen Plasmid 
Maxi kit. Sterile plasticware and autoclaved glassware were used. 20 ml 
ampicillin-containing LB-medium was mixed with a bacterial culture and 
incubated overnight while shaking at 37 °C. Afterwards this bacterial culture 
was mixed with 2000 mL of the ampicillin-containing LB-medium and 
incubated once more under the same conditions. The bacteria were centrifuged 
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in 50 mL-tubes (Megafuge, 4000 rpm, 15 min, 4 °C). The purification of the 
plasmid DNA was performed according to the manufacturers‟ recommendation. 
After the precipitation, the plasmid DNA was placed in sterile endotoxin-free 
water. The concentration of DNA was determined by UV spectroscopy at 
λ=260-280 nm using a photometer UV1202. The solution of DNA was stored at 
-20 °C. 
LB medium: 
10 g L
-1
 Pepton-hydrolysate 
10 g L
-1
 NaCl 
5 g L
-1
 yeast extract 
100 µg ml
-1
 ampicillin 
 
3.3 Cell culture methods and experimental procedures 
All cell culture work was carried out with sterile solutions and devices in a 
laminar flow hood.  
The inorganic salts were all of p.a. quality. Ultrapure water (Purelab ultra 
instrument from ELGA) was used for all preparations.  
We used DNA (sodium salt) from salmon testes (16.2 A250 units mg
-1
 solid; 
6.13 % Na) from Sigma and pcDNA3-EGFP purified with a NucleoBond
®
 PC 
10000 EF kit and Qiagen Plasmid Maxi kit as described above. 
siRNA was purchased by Invitrogen (Paisley, UK): sense, 5´-
GCAAGCUGACCCUGAAGUUCAU-3´; antisense, 5´-
AUGAACUUCAGGGUCAGCUUGC-3´. 
CpG was obtained from Eurofins MWG GmbH (Eurofins MWG, Ebersberg, 
Germany): 5´-TCCATGACGTTCCTGACGTT-3´. Poly(I:C) (double-stranded 
homopolymer) was purchased from Sigma-Aldrich, Germany.   
shRNAs were synthesized by the reverse-transcriptase polymerase chain 
reaction by our collaboration partner Mustapha Oulad-Abdelghai in the Institut 
de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Collège de 
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France, Strasbourg Cedex, France. The primer sequences were as follows: 
Osteopontin (81 bp) CTCAGGCCAGTTGCAGCC and 
CAAAAGCAAATCACTGCAATTCTC, Osteocalcin (70 bp) 
GAAGCCCAGCGGTGCA and CACTACCTCGCTGCCCTCC. 
 
3.3.1 Cultivation of secondary cell lines 
T24 and NIH3T3 cells were cultivated in RPMI 1640 with 10 % fetal calf serum 
(FCS), 2 mM glutamine, 100 U mL
-1
 penicillin, and 100 U mL
-1
 streptomycin 
(culture medium) at 37 °C and in humidified atmosphere with 5 % CO2. HeLa-
EGFP cells were cultivated in the DMEM low glucose medium with 10 % FCS, 
2 mM glutamine, 100 U mL
-1
 penicillin, 100 U mL
-1
 streptomycin and 
50 µg mL
-1
 G418 at 37 °C and in humidified atmosphere with 10 % CO2. 
About once a week the cells were washed twice with PBS (137 mM NaCl, 
2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4), then diluted with 1 mL 
0.25 % trypsine and centrifuged with 6 mL of the medium containing FCS 
(Biofuge, 900 rpm, 5 min, 25 °C). Afterwards the supernatant with the rests of 
the trypsine was removed and the cells were resuspended in the fresh cell culture 
medium and placed into a new 75 cm
3
-flask.  
 
T24 and NIH3T3 culture 
medium: 
RPMI 1640  
10 % FCS 
2 mM glutamine 
100 U mL
-1
 penicillin  
100 U mL
-1
 streptomycin 
 
HeLa-EGFP culture medium: 
DMEM low glucose 
10 % FCS 
2 mM glutamine 
100 U mL
-1
 penicillin  
100 U mL
-1
 streptomycin 
50 µg mL
-1
 G418 
PBS: 
137 mM NaCl 
2.7 mM KCl 
1.44 g L
-1
 Na2HPO4 
0.24 g L
-1
 KH2PO4 
 
3.3.2 Cryoconservation of cells  
For cryoconservation, the cells were washed with PBS, then trypsinized and 
centrifuged. Afterwards the cells were resuspended in 5 mL of the cell culture 
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medium, 1 mL was removed, placed into a cryotube (Nunc, Darmstadt, 
Germany) and mixed with 100 μL DMSO (dimethyl sulfoxide). Afterwards the 
cells were slowly cooled down during more than 24 h to -80 °C and then stored 
in liquid nitrogen. 
 
3.3.3 Defrosting of cells 
The cells were defrosted at 37 °C for about two minutes, then in the first 5 min 
5 mL of the cell culture medium were added dropwise to avoid an osmotic lysis.  
Afterwards the cells were centrifuged (Biofuge, 900 rpm, 5 min, 25 °C), and 
dissolved in fresh cell culture medium with 10 % FCS. After 24 h the medium 
was exchanged to remove the rests of DMSO. 
 
3.3.4 Fluorescence microscopy 
The fluorescence microscopy of EGFP-expressing cells was done by an inverse 
microscope (Olympus IX 51, Olympus, Hamburg, Germany) on unfixed cells in 
the cell culture plates with a suitable fluorescent filter.  
Fura-2 measurements were carried out on Olympus IX 81 motorized inverted 
microscope controlled by the Cell^M software (Olympus Soft Imaging Solution, 
Münster, Germany). During 7 h of experiments, Fura-2 was alternately excited 
at 340 and 380 nm every 3 min and the emitted fluorescence was detected at 
>500 nm. The changes of the Fura-2 fluorescence were analyzed offline using 
the Cell^M software. 
3.3.5 Preparation of calcium phosphate nanoparticles substituted with Al
3+
 
and Mg
2+
 
Solutions of Ca(NO3)2  with additives (Mg(NO3)2 or AlCl3) and (NH4)2HPO4 
(3.74 mM) were mixed with a peristaltic pump at the maximum speed. The 
concentrations of calcium, magnesium and aluminum salts are shown in 
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Table 4.1.1.1 (Section 4.1). Immediately thereafter the dispersion of calcium 
phosphate was taken with an Eppendorf pipette and mixed with 0.1, 0.2, 0.5 or 
1.0 mL of the DNA solution (from salmon testes; 1 mg mL
-1
) for each 
experiment, respectively.  The pH of the solutions was adjusted with 0.1 M 
NaOH to 7.0, 8.0 and 9.0 for each experiment, respectively. 
For the transfection we used 0.2 mL of pcDNA3-EGFP solution (1 ml mL
-1
) per 
mL of the calcium phosphate dispersion and pH 9 as the optimal parameters for 
the synthesis of monodisperse nanoparticles.  
 
3.3.6 Cell transfection  
The T24 cells were cultivated in RPMI 1640 with 10 % FCS at 37 °C and in 
humidified atmosphere with 5 % CO2. Approximately 12 h before the 
transfection, the cells were trypsinized and seeded in cell culture plates with 
5∙104 cells per 24-well plate or 105 cells per 35 mm-dish.  
pcDNA3-EGFP which encodes the fluorophor protein EGFP (enhanced green 
fluorescent protein) was purified from E. coli using Nucleobond
®
 PC 10000 EF 
kit (Macherey-Nagel, Düren, Germany) or Qiagen Plasmid Maxi kit (Qiagen, 
Hilden, Germany). The duration of the transfection was 7 h. Afterwards the 
transfection medium was replaced with the fresh medium. The efficiency of the 
transfection was measured after approx. 48 h by transmission light microscopy 
and by fluorescence microscopy. 
 
Transfection with Polyfect
®
 
Transfection with the commercial agent Polyfect
® 
(Qiagen, Hilden, Germany) 
was carried out according to the manufacturer‟s recommendation: 2 µg DNA 
were dissolved in 100 µL medium without FCS to which 22 µL Polyfect
®
 
solution were added. 5 min after the mixing, 800 µL of the cell culture medium 
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(RPMI 1640 with 10 % FCS or L 15) were added. When the transfection was 
performed in the 24-well plate, 400 μL of fresh cell culture medium and 200 μL 
of the transfection mixture (0.43 µg DNA) were used per well. When the 
transfection was performed in 35-mm dishes, 800 μL of fresh cell culture 
medium and 400 μL of the transfection mixture (0.87 µg DNA) were used per 
dish. The duration of the transfection was 7 h. After that, the transfection 
medium was replaced with fresh cell culture medium (RPMI 1640 with 
10 % FCS). 
 
Standard calcium phosphate transfection method  
The standard transfection with calcium phosphate was carried out as follows: 
4 µL aqueous DNA solution (1 mg mL
-1
) were mixed with 10 µL of 2.5 M 
CaCl2 solution. The dispersion was incubated at room temperature for 5 min. 
The volume of the dispersion was adjusted to 100 µL with water and 100 µL of 
2·HBS (2·HBS: 280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4, 12 mM 
dextrose, 50 mM HEPES, pH=7.05±0.01) were added. Afterwards 1 mL of the 
cell culture medium was added (RPMI 1640 with 10 % FCS or L 15). The 
culture medium was then removed from the cell culture and the transfection 
mixture was added. If the transfection was performed in the 24-well plate, 
500 µL of the transfection mixture (1.7 µg DNA) were used per well. If the 
transfection was performed in 35 mm-dishes, 1 mL of the transfection mixture 
(3.3 µg DNA, 835 µg Ca) was used per dish. The duration of the transfection 
was 7 h. After that, the transfection medium was replaced with fresh cell culture 
medium (RPMI 1640 with 10 % FCS). 
 
Transfection with custom-made calcium phosphate nanoparticles 
The custom-made calcium phosphate/DNA or magnesium or aluminum 
substituted calcium phosphate/DNA nanoparticles were used for transfection as 
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follows: 20 µL of nanoparticle dispersion were mixed with 500 µL medium 
(RPMI 1640 with 10 % FCS or L 15). Then the cell culture medium was 
replaced with the transfection mixture. If the transfection was performed in the 
24-well plate, 500 µL of the transfection mixture (3.2 µg DNA) were used per 
well. If the transfection was performed in 35 mm-dishes, 1 mL of the 
transfection mixture (6.4 µg DNA, 4.2 µg Ca) was used per dish. The duration 
of the transfection was 7 h. After that, the transfection medium was replaced 
with fresh cell culture medium (RPMI 1640 with 10 % FCS). 
 
Control experiments using CaCl2 solution 
17 μL of CaCl2 solution (6.25 mM) were mixed with 1 mL of Leibovitz L15 cell 
culture medium and then transferred to cells seeded in 35 mm-dishes. After 7 h 
of incubation the transfection mixture medium was removed and replaced with a 
fresh cell culture medium (RPMI 1640 containing 10 % FCS) . 
 
Incubation of control cells for Ca
2+
-imaging 
As control we used T24 cells loaded with Fura-2AM and cultivated in the cell 
culture media (RPMI 1640 or L15 medium, respectively) but without additional 
calcium or transfection agents. 
 
3.3.7 Calculation of transfection efficiency of magnesium- or aluminum-
substituted calcium phosphate nanoparticles  
The efficiency of the transfection was studied by transmission light microscopy 
and by fluorescence microscopy using an IX 51 microscope (Olympus, 
Hamburg, Germany) at a magnification of 200x. If the transfection was 
successful and pcDNA3-EGFP was incorporated into the nuclear DNA, the 
synthesis of the fluorophor protein EGFP took place and the cells showed the 
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green fluorescence. The transfection efficiency was computed by the ratio of the 
cells in which EGFP was expressed to the total examined number of cells. 
 
3.3.8 Ca-imaging using Fura-2AM 
10
5
 T24 cells were seeded on poly-L-ornithine-coated 35mm glass-bottom 
dishes 24 h before the measurement. The next day, the cells were loaded with 
Fura-2 by incubating with 1 mL medium which contained 2.5 µM Fura-2AM 
(Invitrogen - Molecular Probes, Leiden, the Netherlands) at 37 °C and in 
humidified atmosphere with 5% CO2. After 30 min the medium was exchanged 
by Leibovitz L15 medium whose osmolarity was adjusted to that of the RPMI 
medium. Furthermore the medium was supplemented by either the standard 
calcium phosphate transfection mixture, or CaCl2 solution, or single-shell or 
triple-shell calcium phosphate nanoparticles.  
 
3.3.9 Staining of cells with propidium iodide 
To check whether the cells are damaged we additionally marked them with 
propidium iodide. 5 µL of PI solution were mixed with 500 µL of the RPMI 
medium and then added to the cell culture. The cells were incubated with this 
mixture for 30 min at 5 % CO2. Then the cells were washed twice with PBS and 
taken for transmission light microscopy and fluorescence microscopy. 
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3.3.10 Toxicity tests 
The T24 cells were seeded 24 h before the experiment in 24-well plates with a 
cell density of 5·10
4
 cells per well. The MTT-assay was performed after the 7 h 
incubation of cells with different transfection media. The spectrophotometric 
measurements were carried out 7 h, 24 h and 48 h after the addition of the 
transfection media to the cells. 
First, the MTT-stock-solution (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide)  in PBS (5 mg mL
-1
) was prepared and afterwards 
diluted to 1 mg mL
-1
 in the cell culture medium (RPMI 1640 supplemented with 
10 % FCS, 2 mM glutamine, 100 U mL
-1
 penicillin, 100 µg mL
-1
 streptomycin). 
After the mentioned incubation time, the cell culture medium was replaced with 
300 µL of MTT-solution and the cells were incubated for about 1 h at 37 °C and 
5% CO2. Then this solution was removed and replaced with 300 µL DMSO 
solution. The cells were incubated for 30 more minutes under the conditions 
described above and afterwards the 50 µL aliquot was taken for 
spectrophotometric measurements using an ELISA-Reader at λ=560-600nm. 
 
3.3.11 Experiments with radioactive 
45
Ca 
The experiments using 
45
Ca were performed as follows: 24 h before the 
transfection the cells were seeded on 35 mm dishes (Nunc, Langenselbold, 
Germany) with a density of 20·10
4
 cells per dish (5·10
4
 in the case of 
subsequent incubation for a week). We used T24 cells (human bladder 
carcinoma cell line). 
The measurements of radioactivity of the medium and cell lysate were 
performed after 1 h, 7 h, 48 h, and 1 week of incubation of the cells at 37 °C and 
in humidified atmosphere with 5 % CO2. 
After 1 h and 7 h of incubation aliquots of the cell culture medium were taken, 
the rest of the medium was removed, and the cells were three times washed with 
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PBS. Then 200 µL of lysis buffer (1 % Triton X 100, 10 mM Tris HCl, pH 7.4) 
were added and mixed with a pipette tip (up and down) 60 times. A 5 µL aliquot 
was taken to determine the protein concentration, and the rest was taken to 
measure the radioactivity of the cells. 
An aliquot of the cell culture medium and the lysates were mixed with 4 mL of 
the scintillation liquid (Rotiszint eco Plus for hydrophilic samples, Carl Roth, 
Karlsruhe, Germany) and then the activity was measured using a Liquid 
Scintillation Analyzer, Tri-Carb 2800TR. 
After 7 h the medium was changed in all residual samples. Half of the samples 
were washed beforehand three times with PBS to remove 
45
Ca which could be 
attached to the cell surface, but had not yet entered the cells.  After 48 h and 
1 week of incubation, the radioactivity was measured as described above.  
 
Transfection with nanoparticles 
Solutions of CaCl2·2H2O (6.25 mM; Sigma, Steinheim, Germany) and 
45
CaCl2 
(PerkinElmer Life and Analytical Sciences, Boston, MA, USA) were mixed 
together to a final radioactivity of the mixture 2 MBq mL
-1
. The overall calcium 
concentration was still 6.25 mM because the added volume of the 
45
Ca solution 
was negligible. Then 250 µL of the CaCl2 solution (6.25 mM) were rapidly 
mixed with 250 µL of (NH4)2HPO4 (3.74 mM) under constant stirring. Then 
425 µL of the dispersion were taken with an Eppendorf pipette and transferred 
into a new plastic vessel. Then 85 µL of the DNA solution (plasmid pcDNA3-
EGFP, 1 mg mL
-1
) were added for the functionalization of the particles. These 
nanoparticles are denoted "single-shell" in the following.  
In order to produce triple-shell nanoparticles, we subsequently added 213 µL of 
the CaCl2 solution (6.25 mM, 2 MBq mL
-1
), 213 µL of (NH4)2HPO4 (3.74 mM) 
and 85 µL of pcDNA3-EGFP solution (1 mg mL
-1
). 
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40 µL of the nanoparticle dispersion were mixed with 1 mL of the cell culture 
medium (RPMI 1640 supplemented with 10 % FCS, 2 mM glutamine, 
100 U mL
-1
 penicillin, 100 µg mL
-1
 streptomycin) and immediately transferred 
to the cells. The calculated amount of added Ca was 4.2 µg per 35-mm dish 
(1 mL). 
After 7 h of incubation the transfection mixture was removed and in half of the 
dishes just replaced with a fresh cell culture medium. In the other half of the 
dishes, the cells were washed three times with PBS to remove traces of 
45
Ca, and 
then fresh medium was added. 
 
Transfection by the standard calcium phosphate method 
The transfection was performed according to the standard protocol. 4 µL DNA 
(plasmid pcDNA3-EGFP, 1 mg mL
-1
), 10 µL CaCl2 (2.5 M; final radioactivity 
4 MBq mL
-1
), 86 µL distilled H2O, 100 µL 2·HBS and 1 mL medium (RPMI 
1640) were mixed together. Afterwards the cell culture medium was replaced 
with 1 mL of this mixture. The calculated amount of Ca added was 835 μg per 
35-mm dish (1 mL) containing 
45
Ca with an activity of 40 kBq mL
-1
.  
After 7 h of incubation the transfection mixture was removed and in half of 
dishes just replaced with a fresh one. In the other half of the dishes the cells 
were washed three times with PBS to remove traces of 
45
Ca and then fresh 
medium was added. 
 
Control experiments with 
45
Ca in the medium  
17 µL of CaCl2 solution (6.25 mM, 2 MBq mL
-1
) were mixed with 1 mL of the 
cell culture medium and then transferred to cells.  The calculated amount of 
added Ca was 4.2 µg per 35-mm dish (1 mL).  
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After 7 h of incubation the transfection mixture was removed and in half of 
dishes just replaced with a fresh one. In the other half of the dishes the cells 
were washed three times with PBS to remove traces of 
45
Ca and then fresh 
medium was added. 
 
3.3.12 Preparation of cell lysates 
The cell culture medium was replaced with 100 µL of lysis buffer containing 
PMSF (1 mM). Then the cells were incubated for 30 min at 4 °C under constant 
shaking. The lysates were mixed by pipetting and transferred into a 1.5 mL 
Eppendorf vessel. This step and all subsequent steps were performed on ice at 
4 °C. The lysates were centrifuged for 10 min at 14,000 rpm. The clear lysates 
were transferred into fresh 1.5 mL vessels and stored at -20 °C. 
Lysis buffer: 
1% Triton X 100 
10 mM Tris-HCl 
pH 7.4  
 
3.3.13 Determination of the protein concentration 
The protein concentration of the lysates (the preparation of the lysates is 
described in Chapter 3.3.12) was photometrically measured with a Bio-Rad DC 
Protein Assay according to the manufacturer's recommendations on an ELISA-
Reader, using standard calibration solutions of bovine serum albumin (BSA) 
(0.05, 0.1, 0.2, 0.4, 0.8, and 1.6 mg mL
-1
). The measured radioactivity of the cell 
lysates was then normalized to the protein content of the lysate. 
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3.3.14 Preparation of metal surfaces coated with calcium 
phosphate/PEI/DNA-nanoparticles 
For the covering of the titanium plates, first, calcium phosphate/PEI 
nanoparticles were produced. For this, aqueous solutions of Ca(NO3)2·4H2O 
(19.91 mM) and (NH4)2HPO4 (11.94 mM) were adjusted to pH 9 with 1.0 M 
NaOH and then rapidly mixed with a peristaltic pump with a speed of 
1.35 mL min
-1
. Simultaneously to the calcium phosphate solution, the PEI 
solution (2 g L
-1
; Aldrich) was added with a speed of 2.6 mL min
-1
. Then the 
nanoparticles were filtered and dried at room temperature.  
For the coating of the plates, the nanoparticles were resuspended in 2-propanol 
(15.4 mg mL
-1
) via 30 min incubation in the ultrasonic bath. Then, pcDNA3-
EGFP solution was added to the concentration of DNA of 1 µg mL
-1
. 
The titanium plates were coated under the voltage of 50 V for 30 s.  
As control, we used titanium plates coated with calcium phosphate/PEI 
nanoparticles without DNA. This preparation method was the same, only the 
step of the DNA addition was missing. 
 
3.3.15 Transfection from metal surfaces 
NIH3T3 cells were cultivated in RPMI 1640 supplemented with 10 % FCS 
2 mM glutamine, 100 U mL
-1
 penicillin and 100 U mL
-1
 streptomycin at 37 °C 
and in humidified atmosphere with 5 % CO2.  
Just before the transfection, 5∙104 cells were seeded per well in the 24-well plate 
onto the pure titanium plates or titanium plates coated with calcium 
phosphate/PEI and calcium phosphate/PEI/DNA nanoparticles.  
A pcDNA3-EGFP which encodes the fluorophor protein EGFP was purified 
from E. coli using the Qiagen Plasmid Maxi kit. The duration of the transfection 
was 7 h. Afterwards the transfection medium was transferred with fresh 
medium. The efficiency of the transfection was measured after approx. 48 h of 
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cell incubation at 37 °C and in humidified atmosphere with 5 % CO2 by 
fluorescence microscopy, by FACS measurements and by Western Blot 
analysis. For these analyses the titanium plates were replaced into fresh 24-well 
plates (to remove the cells which grew on plastic and not on the titanium plates) 
and twice washed with PBS. 
 
Transfection from metal surfaces coated with calcium phosphate/PEI/DNA- 
nanoparticles 
The titanium wafers (10·10) mm coated with calcium phosphate/PEI/DNA 
nanoparticles were placed into the 24-well plates. Then NIH3T3 cells were 
seeded on the plates and 500 µL of the cell culture medium (RPMI 1640) was 
added.  After 7 h the cell culture medium was replaced with fresh medium.  
 
Transfection from metal surfaces coated with calcium phosphate/PEI-
nanoparticles followed by addition of DNA 
The titanium plates (10·10) mm coated with calcium phosphate/PEI 
nanoparticles were placed into the 24-well plate. Then 4 µL of DNA solution 
(1 mg mL
-1
) was dripped onto the surface and dried at 37 ºC. Afterwards 
NIH3T3 cells were seeded on the wafers and 500 µL of the cell culture medium 
(RPMI 1640) was added.  After 7 h the cell culture medium was replaced with 
fresh medium.  
 
Control experiments with titanium plates 
As controls we used untransfected NIH3T3 cells, and cells transfected with 
either Polyfect
®
 (as described in 3.3.6), or calcium phosphate/PEI or calcium 
phosphate/PEI/DNA dispersions. In these cases cells were transfected from the 
dispersion, but were previously seeded on uncoated titanium plates. The 
Polyfect
®
 transfection protocol is described above.  
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For further controls, 20 µL calcium phosphate/PEI and calcium 
phosphate/PEI/DNA isopropanol dispersions were mixed with 500 µL of the 
cell culture medium and the mixture was transferred to the cells seeded onto 
uncoated titanium plates. 
As another negative control we seeded cells onto the titanium plate coated with   
calcium phosphate/PEI nanoparticles without addition of DNA. Then 500 µL of 
the cell culture medium were added. 
After 7 h the cell culture medium was replaced with a fresh one (RPMI 1640).  
 
3.3.16 Cell fixation 
The titanium plates were transferred into the new 24-well plate and 100 µL of 
0.25 % trypsine solution were added. After several minutes 1 mL of RPMI 1640 
with FCS was added and the cells were transferred into the 1.5 mL Eppendorf 
vessel. Then the cells were centrifuged for 3 min at 2000 rpm (Eppendorf 
5415C), the supernatant was removed and the cells were resuspended in 100 µL 
3 % paraformaldehyde (Janssen Chimika, Belgium), incubated for 10 min at 
room temperature, washed twice with PBS and centrifuged 3 minutes at 
2000 rpm. Then the cells were resuspended in 1 mL of PBS.  
 
3.3.17 Flow cytometry of NIH3T3 cells 
Flow cytometry or FACS analysis (fluorescence activated cell sorting) was 
performed on FACSCalibur
™
 in collaboration with Prof. Dr. M. Köller at the 
BG Kliniken Bergmannsheil, and on CyFlow
®
 SL at the Chair of Molecular 
Neurobiochemistry, Ruhr-University of Bochum. The data were analyzed offline 
using WinMDI 2.9 software. 
Flow cytometry is a technique which allows counting and examining 
microobjects suspended in a stream of fluid (size range of 0.5 µm to 40 µm). 
Flow cytometry is based on the optical signal of the suspended single cell when 
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it passes through a laser beam. The cells which contain a fluorescent protein are 
detected and recorded. 
 
3.3.18 Preparation of multi-shell calcium phosphate nanoparticles 
functionalized with siRNA 
Calcium phosphate nanoparticles were prepared by rapidly pumping an aqueous 
solution of Ca(NO3)2 (6.25 mM or 18 mM) and an aqueous solution of 
(NH4)2HPO4 (3.74 mM or 10.8 mM) into a glass vessel by a peristaltic pump. 
The pH of both solutions was adjusted to 9 with 0.1 M NaOH. Immediately after 
mixing, 108.8 µL of the calcium phosphate dispersion was taken with the 
Eppendorf pipette and rapidly added to 16.2 µL of an aqueous solution of 
double-stranded small interfering RNA (siRNA, 320 µM) in a sterile Eppendorf 
vessel. These nanoparticles were denoted "single-shell". 
To protect siRNA from the degradation by nucleases, multi-shell calcium 
phosphate nanoparticles
[100]
 were prepared. First, single-shell nanoparticles were 
prepared as described above. Then 54.4 µL of Ca(NO3)2 (6.25 mM or 18 mM, 
respectively) were added to 125 µL of the above described dispersion of single-
shell particles, and 54.4 µL of (NH4)2HPO4 (3.74 mM or 10.8 mM, respectively) 
were quickly added. The third layer consisting of siRNA was prepared by 
adding 16.2 µL of dsRNA (320 µM) to this dispersion. The initial concentration 
of the double-stranded small interfering RNA (siRNA) used was 320 µM. The 
resulting concentration of siRNA in these dispersions of nanoparticles was 
45 µM.  
 
3.3.19 Preparation of calcium phosphate nanoparticles functionalized with 
CpG and Poly(I:C) 
For the preparation of the oligonucleotide-functionalized calcium phosphate 
nanoparticles, aqueous solutions of Ca(NO3)2·4H2O (6.25 mM) and (NH4)2HPO4 
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(3.74 mM) were adjusted to pH 9 with 0.1 M NaOH and then rapidly mixed via 
peristaltic pump in a plastic vessel. Immediately thereafter, 1 mL of the mixture 
was taken with the Eppendorf pipette and mixed with 167 µL of CpG solution 
(63 µM) or with 2.5 µL of CpG solution (63 µM) and 198 µL Poly(I:C) solution 
(1 mg mL
-1
). 
 
3.3.20 Preparation of calcium phosphate nanoparticles functionalized with 
shRNA 
The single- and triple-shell calcium phosphate/shRNA nanoparticles were 
prepared by the precipitation method as described in Section 3.3.18.
[100]
 We used 
two types of shRNA: Spp1 for the silencing of osteopontin expression and 
Bglap-rs 1 for silencing of osteocalcin expression. The concentrations of shRNA 
were 0.75 mg mL
-1
 and 0.83 mg mL
-1
 for Spp1 and Bglap-rs 1, respectively.  
First, aqueous solutions of Ca(NO3)2·4H2O (6.25 mM) and (NH4)2HPO4 
(3.74 mM) were adjusted to pH 9 with 0.1 M NaOH and then rapidly mixed 
with two peristaltic pumps in a plastic vessel. Immediately thereafter, 1 mL of 
the mixture was taken with the Eppendorf pipette and mixed with 0.1 mg of 
shRNA dissolved in water. These nanoparticles consisted of a calcium 
phosphate core and an outer layer of shRNA for electrostatic and steric 
functionalization and are denoted "single-shell" in the following.  
The shRNA was incorporated into the particles, and then 0.5 mL of 
Ca(NO3)2·4H2O solution (6.25 mM) and 0.5 mL of (NH4)2HPO4 solution 
(3.74 mM) were added to the dispersed single-shell nanoparticles. Immediately 
thereafter, we added 0.1 mg of shRNA dissolved in water as an outer layer of 
the particles (0.75 mg mL
-1
 and 0.83 mg mL
-1
 for Spp1 and Bglap-rs 1, 
respectively). These triple-shell particles consisted of a calcium phosphate core 
and further layers of shRNA, calcium phosphate and shRNA. 
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3.4 Physicochemical methods 
3.4.1 Dynamic light scattering  
Dynamic light scattering (DLS) measurements were carried out with a Zetasizer 
instrument (NanoZS, Malvern instruments). 
Dynamic light scattering was used to determine the size of the particles. For this, 
two major assumptions were made: The particles have spherical form and they 
are in Brownian motion.  
Shining a monochromatic light beam onto dispersion with spherical particle 
causes a Doppler shift when the light hits a moving particle, changing the 
wavelength of the incoming light. This change is related to the size of the 
particle. It is possible to calculate the distribution of particle sizes and give a 
description of the particle‟s motion in the medium, measuring the diffusion 
coefficient of the particle: 
DT = kB T / 6 π ηRh 
DT:  the translation diffusion coefficient 
kB: Boltzmann constant 
T: temperature in Kelvin degrees 
η: viscosity of the solvent 
Rh:  hydrodynamic radius. 
The radius of the particles can be computed from the formula above. 
 
3.4.2 Zeta potential measurements  
The measurements of the zeta potential (ZP) were carried out with a Zetasizer 
instrument (NanoZS, Malvern instruments). 
Zeta potential is the empirical potential on the surface of the particle. It refers to 
the electrostatic potential generated by the accumulation of ions at the surface of 
the colloidal particle which is organized into an electrical double-layer 
consisting of the Stern layer and the diffuse layer.  
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The zeta potential was calculated by measuring the mobility distribution of a 
dispersion of charged particles as they are subjected to electric field. The 
mobility is measured as the velocity of a particle in an applied electric field 
according to the following equation (the Smoluchowski model was used):  
Be = (ε ζ ƒB / η) (ω r
2
T ρ / η) 
Be: electrophoretic mobility 
ε: dielectric constant 
ζ: zeta potential 
η: viscosity 
ω: frequency of the electrical field 
r: radius of the particle 
ρ: density of the dispersion 
ƒB: correction factor 
 
3.4.3 Scanning electron microscopy (SEM)  
For the SEM observations, an ESEM Quanta 400 microscope with gold-
palladium-sputtered samples was used.  
The scanning electron microscope produces very high-resolution images of a 
sample surface which are not possible to be taken by light microscopy because 
of the higher energy of the electrons. In a scanning electron microscope, the 
accelerated electrons are focused by the magnetic field into a narrow beam 
which scans a surface of the sample. The observed image is created by the 
secondary electron emissions from the sample area so that a contrast-rich 3 D-
image can be created. 
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3.4.4 Transmission electron microscopy (TEM) 
TEM observations were performed with a Philips CM 200 FEG instrument on 
air-dried nanoparticles prepared on carbon-coated copper grids.  
The transmission electron microscope is an optical analogue to the conventional 
light microscope. It is based on the fact that electrons possess a wavelength but 
at the same time interact with magnetic fields like a point charge. A beam of 
electrons is applied instead of light, and glass lenses are replaced by magnetic 
lenses.  
A very thin slice of the tested material is exposed to a beam of electrons. Due to 
the interaction of the electrons with a consistent material structure, a constant 
fraction of the electrons is transmitted through the sample to the detector. Once a 
structural imperfection is encountered, the fraction of the transmitted electrons 
changes.  
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4 Results and Discussion 
4.1 Calcium phosphate nanoparticles substituted with Al
3+ 
and Mg
2+
 
4.1.1 Synthesis and characterization of calcium phosphate substituted with 
Al
3+ 
and Mg
2+
 
Nanoparticles represent a key to a very wide range of problems that can be 
solved with the help of nanotechnology. One of their possible applications is the 
use of nanoparticles as carriers for drugs and nucleic acids in molecular biology 
and medicine.  
In the past years many types of nanocarriers of different chemical nature were 
developed and tested. One of the most promising groups is inorganic 
nanoparticles. 
Inorganic nanoparticles may consist of different elements: gold,
[71]
 silver,
[75,76]
 
magnetite,
[77-79]
 silica,
[80]
 carbon,
[81]
 manganous phosphate
[82]
 and calcium 
phosphate. Among this wide range of materials the calcium phosphates draw our 
attention due to their special properties: It is a natural biomineral so it possesses 
outstanding biocompatibility and biodegradability.  Also, the originating ions 
are deeply involved in cell metabolism and can be easily metabolized by cells. 
As drug carriers, calcium phosphate nanoparticles have a number of promising 
properties. They can be dissolved at low pH (around 4), e.g. in the lysosomes 
after the cellular uptake,
[92,106]
 or in the environment of solid tumors, thereby 
releasing the incorporated drugs or biomolecules. Their size can be easily 
controlled by stabilizing agents, such as polymers or nucleic acids. The 
nanoparticles can be made fluorescing by the incorporation of lanthanide 
ions,
[107-110]
 and also act as carriers for different drugs, e.g. insulin
[111]
 and 
cisplatin.
[112,113]
 Kester et al. produced calcium phosphate nanoparticles 
functionalized with the anticancer drug ceramide.
[114]
  Further functionalization 
of the particles with PEG resulted in the stable particles with a positive surface 
charge which were easily taken up by the cells.
[115]
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As carriers of nucleic acids, calcium phosphate nanoparticles have been used 
since 1973.
[83]
 Welzel et al. developed a method of controlled precipitation of 
spherical calcium phosphate nanoparticles functionalized with DNA. Such 
nanoparticles  had  a  size  up  to  200  nm  with  a  negative zeta potential up to 
-30 mV.
[99,116]
 
In order to obtain smaller nanoparticles we used substitutions of aluminum and 
magnesium to inhibit the crystal growth. For the synthesis of the nanoparticles 
we prepared solutions of different composition (Table 4.1.1.1).  
The substitution of cations was used to elaborate the influence of the charge and 
the individual properties of calcium on the precipitation of calcium phosphate 
nanoparticles. Magnesium has chemical properties very similar to those of 
calcium and can also partially replace this ion in many crystals.
[117]
 Therefore, 
we tried to replace almost all calcium in our samples to see its individual 
contribution.  
Aluminum has a higher charge than calcium which could be good for the 
adsorption of the negatively charged phosphate groups of DNA on the 
nanoparticle surface. However, a large amount of aluminum is toxic for cells,
[118]
 
so we only partially substituted calcium with aluminum. In addition, magnesium 
and aluminum are known to inhibit the growth of calcium phosphate crystals 
resulting in smaller particles, which can be easier taken up by cells.
[82,117,119-121]
  
Chowdhury et al. successfully incorporated fibronectin and Mg
2+
 into calcium 
phosphate particles in order to achieve a higher transfection efficiency than the 
classical precipitation method.
[120]
 Bhakta and co-workers used magnesium 
phosphate nanoparticles to transfect HeLa cells and achieved a transfection 
efficiency comparable to that of Polyfect
®
.
[82]
 
So, in our experiments the calcium ions were partially or fully replaced with 
alternative cations. We reduced the calcium concentration in solution and 
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replaced it with adequate concentrations of magnesium or aluminum as shown 
in Table 4.1.1.1. 
Solutions of calcium nitrate with substitutions (magnesium nitrate or aluminum 
chloride) and diammonium hydrogen phosphate with previously adjusted pH 
value were mixed with a peristaltic pump at the maximum speed. Immediately 
thereafter the dispersion of calcium phosphate was taken with an Eppendorf 
pipette and mixed with a DNA solution (from salmon testes, 1 ml mL
-1
) for 
functionalization and stabilization of the nanoparticles. 
 
Table 4.1.1.1:  The composition of solutions used for nanoparticle synthesis. 
Sample 
Concentration / mM pH Concentration / mM pH 
[Ca
2+
] [Mg
2+
] [Al
3+
] [PO4
3-
] 
CaP 6.25 - - 
7 
3.74 
7 
8 8 
9 9 
CaMgP-1 5.21 1.04 - 
7 
3.74 
7 
8 8 
9 9 
CaMgP-2 3.13 3.13 - 
7 
3.74 
7 
8 8 
9 9 
CaMgP-3 1.04 5.21 - 
7 
3.74 
7 
8 8 
9 9 
MgP - 6.25 - 
7 
3.74 
7 
8 8 
9 9 
CaAlP-1 5.21 - 1.04 
7 
3.74 
7 
7.5 8 
7.5 9 
CaAlP-2 4.17 - 2.08 
7 
3.74 
7 
7.5 8 
7.5 9 
CaAlP-3 3.13 - 3.13 
7 
3.74 
7 
7.5 8 
7.5 9 
In order to find the optimal conditions for the nanoparticles synthesis we used 
different amounts of DNA for the stabilization of dispersion. We varied the 
Anna Kovtun, Dissertation 2009 
 
48 
 
amount of DNA (1 mg mL
-1
) per 1 mL of calcium phosphate dispersion: 0.1, 
0.2, 0.5 and 1.0 mL of DNA. 
We also tested the influence of the pH on the particle precipitation. We adjusted 
the pH from 7 to 9 in all solutions of inorganic salts with 0.1 M NaOH for each 
combination of Ca
2+
/Mg
2+
. For experiments with Ca
2+
/Al
3+
 we adjusted the pH 
from 7 to 7.5, because of the precipitation of aluminum hydroxide at higher pH. 
The general aim was to obtain small monodisperse nanoparticles because the 
small particles can more easily penetrate the cell membrane and can be used as a 
carrier in gene therapy. The schema of nanoparticle preparation is shown in 
Figure 4.1.1.1. 
 
 
Figure 4.1.1.1: Schematic representation of synthesis of DNA-functionalized 
calcium phosphate nanoparticles partially or fully substituted with magnesium 
or aluminum. 
 
All the samples were measured via dynamic light scattering (DLS). At all tested 
pH values, the nanoparticles functionalized with 0.1 and 1.0 mL of DNA per mL 
of the calcium phosphate dispersion showed the highest polydispersity index 
(0.7-1.0) at each pH indicating that the dispersions were not stable. Presumably 
with 0.1 mL of DNA the concentration of the nucleic acid was too low to 
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stabilize the nanoparticles, whereas with 1.0 mL DNA the dispersion contains 
too much organic matrix, so the chains of DNA are “swimming” between the 
calcium phosphate cores connecting them as one net. At pH 7 in all the samples 
only the large aggregates were observed. Moreover, in all cases the PDI was 
between 0.6 and 1.0 which means that data are unreliable because of large 
measurement error.  
At pH 8 also almost all the samples showed large aggregates and PDI 0.5-1.0. 
The particles also were too polydisperse to be correctly analyzed by Zetasizer.  
These data could be explained by the individual properties of the DNA 
molecules. Comparing to the synthetic polymers, DNA is a very complex 
molecule whose conformation is strictly determined by the presence of foreign 
ions and proteins. Even a rather short circular plasmid with approx. 5,000 bp 
could have different conformation, i.e. three-dimensional structure (linear, 
circular or supercoiled) and, thus, different availability of phosphate groups for a 
binding. Therefore, interaction of the DNA with calcium phosphate does not 
have a well-defined geometry. Thus, PDI 1.0 can also be measured even for the 
pure DNA solution because of the different conformations and cross linking of 
the DNA chains. It complicated the interpretation of the obtained data. However, 
when the nanoparticles have more define structure, the PDI can be reduced. 
At pH 9 the PDI of the samples was smaller (0.2-1.0) and some data could be 
taken into account.  If we used 0.2 mL of DNA per mL of the calcium phosphate 
dispersion the PDI was usually between 0.2 and 0.5. In this case we observed 
not only large aggregates but also the nanoparticles of 120-170 nm. The DLS 
data are shown in Table 4.1.1.2. 
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Table 4.1.1.2: Size distribution of the DNA-functionalized calcium phosphate 
nanoparticles synthesized at pH 9. Dynamic light scattering data show intensity 
statistics and are presented only for particles smaller than 250 nm. Large 
aggregates of DNA (>1 µm) were always present. 
Sample 0.2 mL DNA per mL of calcium phosphate dispersion  
PDI Size of small particles / nm % 
CaP  0.3 174 
28 
78 
9 
CaMgP-1  0.4 167 9 
CaMgP-2  0.5 160 9 
CaMgP-3  0.6 155 14 
MgP 0.8 180 
37 
62 
38 
CaAlP-1  0.2 123 81 
CaAlP-2  0.5 171 100 
CaAlP-3  1.0 36 100 
 
For better control of the precipitation process we tried to produce the 
nanoparticles at low temperature to slow down the crystal growth and therefore 
to obtain smaller and more monodisperse particles. For this all solutions were 
first cooled down to 4 ºC and then put into an ice bath as shown in Figure 
4.1.1.2. 
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Figure 4.1.1.2: Schematic setup of nanoparticle synthesis at 4 ºC. 
 
Solutions of calcium nitrate with substitutions (magnesium nitrate or aluminum 
chloride) and diammonium hydrogen phosphate were mixed with a peristaltic 
pump at the maximum speed. Immediately thereafter the dispersion of calcium 
phosphate was taken with an Eppendorf pipette and mixed with a pre-cooled 
DNA solution (1 ml mL
-1
) as shown in Figure 4.1.1.2. We used 0.2 mg of DNA 
per mL of the calcium phosphate dispersion and pH 9 as the optimal parameters 
for the synthesis of monodisperse nanoparticles.  
The obtained nanoparticles were characterized by scanning electron microscopy 
and DLS. DLS measurements of all samples showed large aggregates with very 
high PDI (usually around 0.7). However, the small nanoparticles with a size of 
50-120 nm were present in each sample. The zeta potential of all particles was 
always negative around -30 mV.  
To check the DLS data we performed scanning electron microscopy of the 
particles. It showed a much smaller particle size than that obtained by DLS. 
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Partially it is due to the fact that DLS measurements show the hydrodynamic 
radius of the particles whereas electron microscopy shows an inorganic core. 
Figure 4.1.1.3 shows SEM images of nanoparticles obtained by precipitation at 
4 ºC with and without added magnesium. Pure calcium phosphate nanoparticles 
had a spherical morphology with particle size of 80-100 nm, showing a 
reduction of particle size with an increase of the magnesium content. However, 
morphologically defined particles with a size of 30-50 nm were observed only 
up to a magnesium concentration of 3.13 mM. A further increase of the 
magnesium content led to the formation of two fractions of poorly defined 
spherical particles: 150 nm and 15 nm. Pure magnesium phosphate particles 
show only small particles of approx. 25 nm. 
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Figure 4.1.1.3: Scanning electron micrographs of calcium phosphate 
nanoparticles synthesized with and without magnesium additives at 4 ºC. We 
performed the nanoparticle synthesis at pH 9 and used 0.2 mg of DNA per mL 
of the calcium phosphate dispersion. 
 
The nanoparticles synthesized with aluminum substitutions showed the same 
tendencies (Figure 4.1.1.4).  The particles with low aluminum content showed 
two different morphologies: Needle-like structures and small spherical particles 
with a size around 20 nm. The subsequent increase of aluminum content resulted 
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in small monodisperse but very poorly defined spherical particles with a size 
around 20 nm. 
 
 
Figure 4.1.1.4: Scanning electron micrographs of magnesium phosphate 
nanoparticles and aluminum-substituted calcium phosphate nanoparticles 
precipitated at 4 ºC. We performed the nanoparticle synthesis at pH 9 and used 
0.2 mg of DNA per mL of the calcium phosphate dispersion. 
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These data also correlate with those previously obtained and described in 
Ref.
[121]
 There we showed that the crystallinity of the samples is reduced with an 
increase of foreign cation content. In the samples which contained magnesium 
the completely amorphous structure is reached with a magnesium concentration 
of 5.21 mM (almost complete substitution of calcium ions with magnesium) and 
aluminum concentration of 3.13 mM (partial substitution of calcium with 
aluminum).
[121]
 
 
4.1.2 Transfection with calcium phosphate nanoparticles substituted with 
Al
3+
 and Mg
2+
 
The previously described nanoparticles were investigated as carriers of DNA 
into cells for cell transfection. For these experiments we used NIH3T3 cells (a 
fibroblast cell culture). The cells were cultured in RPMI 1640 medium 
supplemented with 10 % fetal calf serum (FCS), 2 mM glutamine, 100 U mL
-1
 
penicillin and 100 µg mL
-1
 streptomycin at 37 °C under 5% CO2. 24 h before the 
transfection the cells were seeded onto 24-well plates with a density 5·10
4
 cells 
per well. 
The cells were transfected with pcDNA3-EGFP to induce the production of 
enhanced green fluorescent protein (EGFP).
[100,122,123]
 NIH3T3 cells were 
incubated in cell culture medium which contained 40 µL of the nanoparticle 
dispersion per mL of RPMI 1640 for 7 h, then the transfection medium was 
replaced with fresh cell culture medium and the cells were further incubated for 
48 h. The detection of the transfection efficiency was carried out with a 
fluorescence microscope. The efficiency was calculated as a percentage of 
fluorescing cells to the total number of cells.  
As control we used the classical standard calcium phosphate precipitation 
method described by Graham and van der Eb.
[83]
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The results of the transfection are shown in Table 4.1.2.1 and in Figure 4.1.2.1. 
Not all the particle types led to a successful cell transfection. Most of the 
transfection media show very low or no transfection efficiency. 
 
Table 4.1.2.1: Transfection efficiency of magnesium- and aluminum-substituted 
calcium phosphate nanoparticles synthesized at 4 ºC on NIH3T3 cells. 
Sample Transfection efficiency / % 
CaP 5.7 
CaMgP-1 5.5 
CaMgP-2 0 
CaMgP-3 0 
MgP 0 
CaAlP-1 1.5 
CaAlP-2 1.7 
CaAlP-3 0 
Standard precipitation method 6.5 
 
Particles which consisted only of the calcium phosphate core and a DNA shell 
showed transfection efficiency close to that of the standard precipitation method: 
5.7 and 6.5 %, respectively.  The nanoparticles where only a small part of 
calcium was substituted with magnesium (CaMgP-1) showed a similar 
efficiency:  5.5 %, whereas the nanoparticles with higher content of magnesium 
or with aluminum substitutions showed very little or no transfection. There are 
two possible explanations for such low transfection efficiency because the 
particles showed two morphologies in SEM. This could be a result of the poor 
crystallinity of smaller particles as described in Ref.
[121]
 which led to a fast and 
complete dissolution of the nanoparticles in the acidic medium of the 
endosomal/lysosomal compartment or in the cytoplasm and, hence, their 
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inability for successful DNA delivery to the cell nucleus. The larger particles, 
however, could be aggregated in solution, thus forming too large agglomerates 
to be taken up by cells. 
 
 
Figure 4.1.2.1: Transmission micrographs (top row) and fluorescence 
micrographs (bottom row) of successfully transfected cells. Transfection 
experiments were performed with magnesium- or aluminum-substituted calcium 
phosphate nanoparticles on NIH3T3 cells (N=5). 
 
4.1.3 Conclusion 
We were able to synthesize small calcium phosphate nanoparticles. As optimal 
conditions we used pH 9 and 0.2 mg of DNA per mL of calcium phosphate 
dispersion with a partial substitution of calcium with magnesium or aluminum 
and low temperature. Under these conditions, we synthesized nanoparticles with 
a negative zeta potential (around -30 mV), spherical morphology and a size 
around 80-20 nm. However, these nanoparticles were on the one hand 
aggregated in solution. On the other hand, the smaller particles were poorly 
crystalline and can therefore hardly act as gene carriers. This all resulted in low 
transfection efficiency. The transfection efficiency was tested on NIH3T3 cells 
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using pcDNA3-EGFP. The maximal transfection efficiency of 5.7 and 5.5 % 
was found for pure calcium phosphate nanoparticles and magnesium-substituted 
calcium phosphate nanoparticles, respectively. This efficiency was comparable 
to that of the standard calcium phosphate precipitation method. 
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4.2 Tracking of the intracellular calcium level during the transfection of 
cells  
4.2.1 Marking of nanoparticles with 
45
Ca
2+ 
The calcium phosphate transfection method is widely used for many years in 
molecular biology.
[83,89]
  However, the exact mechanism of the transfection, i.e. 
of the DNA entry and intracellular release, remains still unclear. Moreover, a 
poor reproducibility of the method and its relatively high toxicity indicates that a 
more detailed understanding of the process can help enhance the transfection 
efficiency. Sokolova et al. reported a new transfection method based on the 
precipitation of calcium phosphate nanoparticles and their subsequent 
functionalization with plasmid DNA.
[91,99,116]
 The efficiency of this method was 
additionally increased by using additional shells of calcium phosphate for the 
DNA encapsulation, thus protecting it from the enzymatic degradation as shown 
in Figure 4.2.1.1.
[100]
 This method proved to be more efficient then classical 
calcium phosphate method and comparable with the commercial polymeric 
transfection reagent Polyfect
®
. However, the question of the toxicity of the 
method remained unclear. Usually the intracellular calcium concentration is 
maintained on a very low level (around 10
-10
 M according to Ref. 
[117]
) and its 
increase could lead to the disturbance of calcium-dependent signaling pathways 
or even intracellular osmotic balance, which could be both fatal for cell. 
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Figure 4.2.1.1: Schematic representation of single- and triple-shell 
nanoparticles. 
 
Here we analyzed the comparative toxicity of calcium phosphate-based methods 
and the distribution of calcium phosphate inside the cells to better understand 
the calcium phosphate-based transfection mechanisms for the further application 
of nanoparticles in vivo. 
To reach a successful transfection, DNA should enter the cell by endocytosis 
and undergo subsequent nuclear targeting (Figure 4.2.1.2).
[38,39,124]
 Loyter et al. 
reported that calcium phosphate precipitates enter the cell by endocytosis after 
about 1-2 h.
[125]
 These data were also confirmed for the TRITC-BSA-marked 
nanoparticles by Sokolova et al.
[126]
 The CaP-DNA precipitates should escape 
the endosome before its fusion with lysosome to prevent the lysosomatic 
degradation of DNA. In the lysosome, the proton pump induces pH decrease 
followed by the dissolution of calcium phosphate and the release of DNA. There 
the DNA will be later cleaved by lysosomal nucleases. Thus, DNA needs to 
leave the lysosome before the protective calcium phosphate will be completely 
dissolved and it becomes available for nucleases. Nevertheless, Maitra
[92]
 
indicated that partial dissolution of calcium phosphate can destabilize the 
lysosomal membrane and enhance the release of remaining nanoparticle and 
DNA into the cytoplasm. There DNA will move in the direction of the 
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nucleus.
[38,126]
 However, it is still unclear whether the nanoparticle itself 
penetrates the nuclear membrane, or whether the DNA enters the nucleus alone. 
Figure 4.2.1.2 shows a schematic representation of the transfection mechanism.  
 
 
Figure 4.2.1.2: Schematic representation of the transfection mechanism. A: 
Nanoparticle attaches to the cell membrane; B: Nanoparticle enters the cell by 
endocytosis; C: Endosomal escape; D: Nuclear targeting (nanoparticle or 
detached DNA enters the nucleus). 
 
Sokolova et al. showed that after 6 h of transfection the nanoparticles were 
concentrated in the nuclear region. Loyter et al. and Orrantia and Chang 
indicated that nanoparticles can also enter the nucleus.
[38,125]
 Inside the nucleus, 
DNA can be directly expressed, resulting in a transient transfection (that will 
disappear after several cell division cycles), or intercalate into the genome 
resulting in a stable transfection. However, how the calcium phosphate-based 
transfection influences the intracellular calcium balance was never investigated. 
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Nevertheless, Ewence et al. recently reported that calcium phosphate crystals 
from the atherosclerotic plaques induced a rapid increase of the intracellular 
calcium concentration which caused the death of 50 % of the investigated 
vascular smooth muscle cells.
[106]
 They also found that this increase occurs due 
to the dissolution of calcium phosphate crystals in the lysosomes which causes 
the rupture of the latter, an overall increase of calcium concentration in the 
cytoplasm, and, finally, cell death. Thus, we were interested to find out, which 
side effects can occur during the calcium phosphate-based transfection, and 
whether it also causes cell damage or cell death. 
We investigated the maintenance of calcium balance during calcium phosphate-
mediated transfection techniques on T24 cells (a human bladder carcinoma cell 
line). To follow the intracellular calcium we used the radioactive calcium 
isotope, 
45
Ca
2+
 as calcium chloride solution, which emits β-radiation and has a 
half-life period of 162 days. Thus, we could differentiate between calcium taken 
up by cells and remaining in the medium. We performed the classic calcium 
phosphate transfection
[39,83,127,128]
 and transfection with single-shell calcium 
phosphate nanoparticles as described by Welzel et al.
[116,129]
 and multi-shell 
nanoparticles as described by Sokolova et al.
[91,100]
 As controls we used 
untreated cells and cells incubated with the same amount of dissolved calcium 
ions (as calcium chloride solution) to examine the intracellular calcium level 
under the conditions of increase of the calcium concentration in cell culture 
medium. A scheme of the transfection experiments is shown in Figure 4.2.1.3. 
After each indicated time point (1 h, 7 h, 48 h and 1 week after the transfection) 
an aliquot of the cell culture medium was taken to measure the radioactivity of 
the medium. Simultaneously, the cells were lysed with a 1 % Triton X-100 
buffer and one aliquot of the lysate was used to measure the intracellular protein 
concentration, whereas another aliquot was used for the radioactivity 
measurement. 7 h after the transfection the cell culture medium contained 
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45
calcium was replaced with a fresh medium without 
45
Ca
2+
. Thus, 48 h and 1 
week after the transfection the detectable amount of calcium was much lower 
and only calcium which was pumped out of the cells or was adsorbed on the cell 
membrane was detected. 
 
 
Figure 4.2.1.3: Schema of the transfection experiments. Top schema: Types of 
transfection media used to test the amount of calcium taken up by the cells 
during transfection. Bottom schema: Experimental time points. The time points 
of radioactivity measurements are indicated by dotted arrows.  
 
The results of radioactive measurements are shown in Figures 4.2.1.4. and 
4.2.1.5. The addition of the 
45
CaCl2 solution alone to the cell culture medium had 
almost no influence on the intracellular calcium balance. The calcium ions 
remained in the medium and only a very small amount of calcium penetrated the 
cell membrane and was detected in the cell lysates. This corresponds to the 
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generally known data of the stability of the intracellular ionic balance: The 
intracellular calcium concentration is maintained on a very low level (lower than 
10
-10
 M).
[117]
 
However, after the incubation of the cells with the standard calcium phosphate 
precipitates for 1 or 7 h, the amount of calcium detected in the cell culture 
medium did not differ from the theoretical value, i.e. from the added to the 
medium amount of radioactive 
45
calcium (Figures 4.2.1.4). This happened 
presumably due to the very small volume of cells compared to the volume of 
medium. Therefore, such minor changes were not possible to detect. The 
application of calcium phosphate/DNA nanoparticles showed also only minor 
decrease of 
45
calcium concentration in the medium.  
After 7 h of incubation of cells with transfection media, the media were replaced 
with fresh medium without 
45
calcium and therefore only the calcium which was 
already taken up by cells and then pumped out could be detected. So, after 48 h 
and 1 week of the incubation only the intracellular calcium or calcium adsorbed 
on the cell membrane was detected. These values also did not differ between all 
three methods, although they were much smaller than the values detected for the 
first 7 h.  
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Figure 4.2.1.4: The radioactivity of 
45
Ca per µL cell culture medium at different 
time points after the incubation with different transfection media. The arrow 
indicates the medium exchange after the transfection. The radioactivity of 
control (untreated) cells was always very close to zero and, therefore, is not 
shown on the diagram. The error bars represent the standard error of the mean 
(N=4). 
 
The analysis of the cell lysates is shown in Figure 4.2.1.5. We observed that the 
maximum intracellular 
45
calcium concentration was achieved after 7 h of 
incubation of cells with calcium-containing dispersions, independent from the 
transfection method. Nevertheless, the amount of intracellular calcium was very 
different for each method.  The application of calcium phosphate nanoparticles 
for the transfection resulted in a much smaller increase of the intracellular 
calcium concentration than that of standard calcium phosphate precipitates (7 
times).  Although the transfection efficiency of the calcium phosphate 
nanoparticles and the standard calcium phosphate precipitates was equal, as 
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shown in Section 4.1 and in Ref.
[100]
, the amount of calcium used per well was 
very different (we used 4.2 µg and 835 µg of Ca per mL of cell culture medium, 
respectively), as well as the amount of detected intracellular calcium 7 h after 
the transfection. Nevertheless, the ratio of the intracellular calcium 
concentration between cells transfected with the standard method and 
nanoparticles was only 7 times, whereas the difference in the added amounts of 
calcium for the transfection was almost 200 times. Such differences are due to 
the optimized transfection protocols described in Ref. 
[83,100]
 Thus, we used stock 
solutions of CaCl2 of concentrations 2.5 M and 6.25 mM for synthesis of 
calcium phosphate precipitates in the case of the standard calcium phosphate 
transfection method and calcium phosphate nanoparticles, respectively. 
Therefore, the smaller amount of calcium in the form of DNA-functionalized 
calcium phosphate nanoparticles was far more effective.  
48 h and 1 week after the transfection, the intracellular calcium level was still 
very high for cells treated with the standard calcium phosphate precipitates. That 
means that the fast increase of the calcium concentration during the transfection 
(first 7 h) made it almost impossible for the cell to pump out all the excessive 
calcium during the further incubation time. In contrast, the transfection of the 
cells with calcium phosphate/DNA nanoparticles resulted in a reduction of the 
intracellular calcium concentration to the base level within 48 h.   
The addition of CaCl2 solution alone to cell culture medium had almost no 
influence on the intracellular calcium balance. The calcium ions remained in 
medium and only a very small amount of calcium has penetrated the cell 
membrane and was detected in the cell lysates.  
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Figure 4.2.1.5: The radioactivity of 
45
Ca of the cell lysates per µg protein at 
different time points after the incubation with different transfection media. An 
arrow indicates the medium exchange after the transfection. The radioactivity of 
control (untreated) cells was always very close to zero. The error bars represent 
the standard error of the mean. For standard precipitation method and calcium 
phosphate nanoparticles the significance is P<0.05 (N=4). 
 
To check whether all calcium was taken up during the first 7 h of transfection 
and not later, we washed all the samples three times with PBS after the first 7 h 
of transfection to remove all the particles or calcium ions that were attached to 
the cell membrane. Afterwards the cells were incubated for further 48 h or 1 
week in cell culture medium without 
45
calcium. Surprisingly, the amount of 
intracellular calcium was much smaller for the samples which were washed with 
PBS (Figure 4.2.1.6). That means that the calcium phosphate nanoparticles or 
calcium ions were partially adsorbed on cell surface but not yet inside the cells 
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so that they could be easily removed by additional washing steps before the 
medium change. However, when these washing steps were not performed, the 
particles or ions would be easily taken up by cells during the further incubation 
time and will also contribute to the successful transfection. Moreover, however 
minor the real intracellular calcium concentration after the washing steps was, 
the highest content of 
45
calcium was still observed after the standard calcium 
phosphate transfection. The additional argument is that in a possible application 
of the gene therapy in vivo it will be impossible to wash the cells with PBS. 
Therefore, we can only conclude that most of the calcium phosphate 
nanoparticles or calcium ions are adsorbed on the cell membrane during the first 
7 h of transfection and will enter the cell only during further incubation time. 
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Figure 4.2.1.6: The radioactivity of 
45
Ca per µL of the cell culture medium (A) 
and per µg of protein in the cells (B) after the incubation with different 
transfection media. After the 7 h of transfection the cells were washed three 
times with PBS to remove all calcium attached to the cell membrane and to 
exclude its subsequent penetration into the cells. The arrows indicate very low 
calcium content in the samples. The error bars represent the standard error of the 
mean (N=4). 
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4.2.2 Monitoring of the internal calcium level using the calcium-sensitive 
dye Fura-2 
We performed the measurements of intracellular calcium changes in cooperation 
with the group of Prof. R. Heumann at the Chair of Molecular Biochemistry at 
the Ruhr-University of Bochum. The time-lapse microscopy of transfected cells 
was performed mainly by our cooperation partner Sebastian Neumann. 
To confirm the results obtained with radioactive 
45
Ca
2+ 
we also performed the 
measurements of the intracellular calcium concentration using fluorescence time 
lapse microscopy with the calcium-sensitive dye Fura-2. Fura-2 AM is an 
esterified cell-permeant form of the Ca
2+ 
indicator Fura-2, a polyamino 
carboxylic acid. In the cytosol Fura-2 AM is completely cleaved by endocellular 
esterases to Fura-2 which can be excited at two wavelengths: 340 nm and 
380 nm, and it fluoresces at 510 nm. These two excitation wavelengths 
correspond to calcium-bound and calcium-free forms of Fura-2, respectively. 
Therefore the ratio of the emissions at those wavelengths is directly correlated to 
the amount of intracellular calcium.
[130-133]
 Nevertheless, to obtain the 
quantitative data, each measurement must be previously calibrated, i.e. the cell 
must be loaded with a known amount of calcium and Fura-2 AM and the 
quantitative changes could be calculated. In this work we only performed 
qualitative measurements of intracellular calcium concentration to compare 
different methods.   
Fura-2 shows very low cross sensitivity to the other cations (e.g. Mg
2+
, Mn
2+
 or 
Zn
2+
) because of its special three-dimensional structure. Four carboxyl groups 
form a cavity where only one Ca
2+
 ion with a radius 9.9·10
-11 
m suits. If this 
position is occupied by smaller ions, e.g. Mg
2+
, only two carboxyl groups would 
bind it and the complex would not be stable.  
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Figure 4.2.2.1: Structures of Fura-2 and Fura-2AM.
[130]
 Carboxyl groups bind: 
Fura-2, R=H; Fura-2AM, R=-CH2-O-CO-CH3. 
 
Although this dye cannot detect the calcium bound to nanoparticles, it detects 
dissolved ionic calcium. This calcium can be detected after the dissolution of 
nanoparticles inside the cells. The nanoparticles penetrate the cell membrane by 
endocytosis. Afterwards the endocytic vehicle fuses with lysosomes.
[39,92,125]
  
Usually calcium phosphate undergoes partial or complete dissolution in the 
acidic medium of lysosomes after the activation of proton pumps in the 
lysosomal membrane. However, the calcium can on the one hand buffer the low 
pH of the lysosome, thus protecting DNA from the degradation, and on the other 
hand destabilize the lysosomal membrane, so that remained particles or free 
calcium ions can escape the lysosomes. Afterwards the particles and DNA move 
to the nucleus via passive diffusion or active transport by microtubules.
[134-136]
 
The intracellular Ca
2+
 changes are shown with the rainbow3 colour scheme in 
Figure 4.2.2.2 indicating the Ca
2+
-concentration. Whereas the standard calcium 
phosphate method caused high changes of the cytosolic Ca
2+
-concentration, 
nanoparticles gave only a moderate change. One can observe that during 
transfection with standard precipitation method each cell appeared red at a 
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different time, afterwards returning to its previous state. Nevertheless, some 
cells remained red for some hours, which corresponds to a very high 
intracellular calcium concentration. We can predict that this cell will undergo 
apoptosis within some hours (Figure 4.2.2.2).
[106,137,138]
 
In contrast, the cells transfected with single- and triple-shell nanoparticles 
showed no significant changes compared to control cells which were incubated 
only in cell culture medium without additional calcium.  Only local and very 
moderate changes of the calcium concentration were observed. 
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Figure 4.2.2.2: Fluorescence spectroscopic monitoring of the cytosolic Ca
2+
-
level in Fura-2-labelled T24 cells: control cells without additional calcium or 
transfection
 
(A); cells during the transfection by the standard calcium phosphate 
method (B); cells transfected by single-shell calcium phosphate/DNA 
nanoparticles (C) or triple-shell calcium phosphate/DNA nanoparticles (D). 
Changes of the intracellular calcium level are shown with the rainbow3 scheme 
on the right. Magnification in all cases: 200x. 
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We found an interesting tendency: the distribution of the intracellular calcium 
was different in the case of the standard transfection and nanoparticles (Figure 
4.2.2.3).  In the case of the cells treated with the standard calcium phosphate 
precipitates we observed a general increase of the calcium concentration inside 
the cells. Moreover, the increase of calcium was detected in the whole 
cytoplasm of the cells, and not in the defined compartment. That means that 
after the dissolution, calcium destabilized the lysosomal membrane causing big 
calcium spikes and was released into the cytosol. In contrast, cells transfected 
with nanoparticles showed a localized increase of the calcium concentration as 
indicated in Figure 4.2.2.3 with arrows. Presumably, these spikes correspond to 
the local dissolution of nanoparticles inside the lysosomes. 
All these experiments were performed at room temperature, because of the fast 
metabolization of Fura-2 inside the cells at 37 ºC.
[130]
 If the cells were incubated 
inside the incubation chamber for 7 h, Fura-2 was metabolized within 2 to 3 h. 
However, although the calcium balance was impossible to follow for the whole 
7 h, the observations during the first 3 h were the same as with the cells 
incubated at room temperature. Therefore it is likely that the calcium balance 
behaves in the same way at room temperature and at 37 ºC.   
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Figure 4.2.2.3: Distribution of the intracellular calcium in fluorescence 
microscopy (top row) and in the rainbow color scheme as in 3.4.2.1 (bottom 
row) in the control cells (A), during the transfection with the standard calcium 
phosphate method (B), single-shell (C) and triple-shell (D) calcium 
phosphate/DNA nanoparticles. The arrows indicate slightly increased calcium 
levels which are clearly localized in the cytosol of the cells transfected with 
nanoparticles.  
 
Figure 4.2.2.4 shows the disturbance of intracellular calcium inside a single cell. 
The peaks occur at the time when calcium particles are dissolved in the cell 
because only ionic calcium can be detected using Fura-2. The red curve 
represents the ground level of the calcium concentration. In the cells treated with 
a CaCl2 solution or transfected with single or triple-shell calcium phosphate 
nanoparticles, we observed only minor changes in the intracellular calcium 
concentration (green, violet and blue curves). In contrast, in the cells transfected 
with the standard calcium phosphate method large spikes of calcium 
concentration were detected (orange curve). These spikes probably correspond 
to the dissolution of the particles inside the cells. Afterwards the ionic pumps 
were turned on and the calcium concentration returns to the base level. The 
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excessive calcium was pumped into intracellular calcium stores (endoplasmatic 
reticulum and mitochondria) or out of the cell. However, above the critical 
calcium concentration it can become impossible for cell to pump out excessive 
calcium and it will die by apoptosis.
[106,137,138]
 
 
 
Figure 4.2.2.4: Monitoring of the intracellular calcium concentration of T24 
cells (for a selected single cell per experiment) during 7 h of transfection. 
 
However, each cell has its individual occurrence of calcium spikes during the 
transfection, so the statistic processing of these data gives only integrated and 
smoothed results as shown in Figure 4.2.2.5.  
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Figure 4.2.2.5: Monitoring of the intracellular calcium concentration of T24 
cells (N=10 for control cells, N=7 for CaCl2 control experiments, N=23 for the 
standard calcium phosphate method, N=22 for single-shell nanoparticles, N=17 
for triple-shell nanoparticles). 
 
However, even if the analysis of independent peaks in the whole cell culture and 
not in the single cell was very complicated, the vitality of cells was significantly 
reduced. Such a large increase of the intracellular calcium concentration disturbs 
the ionic balance of cells and may cause cell death.  This was confirmed by the 
MTT viability assay. We performed a viability assay on T24 cells transfected 
with different methods: The calcium phosphate standard precipitation method, 
the commercial transfection reagent Polyfect
®
, single-shell and triple-shell 
nanoparticles. Polyfect
® 
is a dendrimer molecule of spherical architecture, 
whose branches terminate at amino groups. These amino groups assemble DNA 
into compact structures and bind to the negatively-charged cell surface. Thus, 
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Polyfect
®
/DNA complexes enter the cell by nonspecific endocytosis. As 
negative control we used untreated cells which were incubated in cell culture 
medium at 37 ºC under 5 % CO2.  
The MTT assay showed a decrease of cell viability in the cells treated with 
standard calcium phosphate precipitates of about 40-50 % (Figure 4.2.2.6). The 
cells transfected with Polyfect
®
 also showed a decrease of cell viability of 20-
25 %. However, cells transfected with nanoparticles (single-shell or triple-shell) 
showed no significant decrease compared to the control. 
 
 
Figure 4.2.2.6: MTT assay after 7, 24 and 48 h of incubation of T24 cells with 
different transfection media (*: P<0.001; **: P<0.05), N=4. 
 
To confirm these results we stained the cells with propidium iodide (PI). This 
dye binds to nucleic acids and cannot penetrate the cell membrane of a healthy 
cell. If the integrity of the membrane is damaged, the dye can pass through the 
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cell membrane, thus staining damaged or dead cells. We stained cell with PI 
48 h after the transfection, then cells were washed twice with PBS and analyzed 
by fluorescence microscopy. 
The results of PI staining are shown in Figure 4.2.2.7. Control cells remained 
healthy and intact, whereas cells with a damaged membrane appeared red. In the 
case of standard calcium phosphate transfection and Polyfect
®
, many cells 
showed a red staining of cytoplasm and nucleus. However, the cells transfected 
with nanoparticles showed very few (equal to the control) red cells. The red dots 
on the images of nanoparticle-transfected cells represent PI bound to the 
particles on the cell surface, but not the intracellular PI. If PI penetrates the cell 
membrane it stains the nucleic acids inside the cells, therefore the whole 
cytoplasm and the nucleus appear red (as in the case of the standard calcium 
phosphate transfection method). If PI is not inside the cells it stains only DNA 
on the nanoparticles, thus PI staining appears only as red dots. These results 
qualitatively confirm quantitative results obtained by using the MTT assay. 
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Figure 4.2.2.7: Transmission light microscopy (upper row) and fluorescence 
microscopy (bottom row) of T24 cells stained with propidium iodide 
(magnification: 200x in all cases) 48 h after the transfection. The red cells 
containing PI are damaged and will die soon.  
 
4.2.3 Conclusion 
We were able to follow the intracellular calcium level during different calcium 
phosphate-mediated transfection methods on T24 cells. We first marked the 
nanoparticles with 
45
Ca
2+
. The maximum increase was observed in the cells 
transfected with the standard calcium phosphate method. In the case of 
nanoparticle-mediated transfection, it was much smaller.  
The results were confirmed by time lapse microscopy using the Ca
2+
-sensitive 
dye Fura-2. We observed the general increase of the intracellular Ca
2+
 
concentration in the cytoplasm during the transfection with the standard calcium 
phosphate method, whereas the transfection with nanoparticles showed a smaller 
and localized increase of calcium concentration. Such a big increase of the 
intracellular calcium concentration can lead to cell death. The vitality test 
performed on T24 cells showed that cells transfected with the standard 
precipitation method suffered a decrease of the cell vitality down to 50 %. 
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4.3 Calcium phosphate nanoparticles functionalized with siRNA against 
EGFP 
4.3.1 Synthesis and characterization of siRNA-functionalized calcium 
phosphate nanoparticles 
Gene silencing represents a very promising approach for gene therapy. It was 
shown that oligonucleotides can be introduced into cells for the endogenous 
regulation of the target gene expression. The mechanism of gene silencing was 
first described in 1998 by Mello and Fire using the roundworm Caenorhabditis 
elegans.
[17]
 Since that time many gene silencing experiments were performed 
with double-stranded small interfering RNAs (siRNA) on different models, e.g. 
the fruit fly Drosophila, trypanosomes and plants.
[12,22,25,26,48,63,139,140]
 They 
showed that the reporter gene expression can be effectively inhibited by siRNA-
induced pre-mRNA cleavage. 
Gene silencing was performed according to Ref.
[139-145]
 with HeLa-EGFP cells 
using multi-shell calcium phosphate nanoparticles functionalized by siRNA 
against the green fluorescing protein EGFP. Double-stranded siRNA containing 
22 nucleotides (22-nt) was shown earlier to induce a strong decrease in EGFP 
expression by post-transcriptional cleavage of the intracellular RNA.
[140]
 As 
shown by Sokolova et al. it down-regulates the intracellular synthesis of EGFP 
by interacting with pre-mRNA which is stably expressed in the HeLa-EGFP cell 
line.
[91]
 Once the mRNA has been cleaved, the synthesis of EGFP cannot occur 
anymore, thus no green fluorescence can be detected. Here we performed the 
experiments using multi-shell calcium phosphate nanoparticles achieving a far 
more effective gene silencing. We used a final concentration of 45 µM siRNA as 
described in Ref.
[95]
 which was found to be optimal for double-stranded 
oligonucleotides.  
The particles were prepared by the precipitation of calcium phosphate at pH 9 
under constant stirring and subsequent functionalization of the particles with 
siRNA (single-shell nanoparticles). In order to produce triple-shell nanoparticles 
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we added further shells of calcium phosphate and siRNA for steric and 
electrostatic stabilization. These shells should protect siRNA in the inner shell 
from the fast enzymatic degradation in the lysosomal compartment and in the 
cytosol.  
The obtained single- and triple-shell calcium phosphate/siRNA nanoparticles 
had a particle size up to 200 nm and a spherical morphology as shown by SEM 
and TEM (Figures 4.3.1.1 and 4.3.1.2). Dynamic light scattering gave an 
average  size  of  single-shell  nanoparticles  of  565  nm with a zeta potential 
of -35 mV for single-shell nanoparticles and 517 nm and -6 mV for triple-shell 
nanoparticles. However, a small amount of sample and the presence of dissolved 
siRNA made it very difficult to record the DLS data. Moreover, in both cases 
the PDI of the dispersion was between 0.5 and 1.0, which means that the data 
are difficult to interpret, and that some aggregation had occurred. 
 
 
Figure 4.3.1.1: Transmission electron micrographs of calcium phosphate 
nanoparticles, coated with siRNA. A: Single-shell nanoparticles; B: Triple-shell 
nanoparticles. 
Anna Kovtun, Dissertation 2009 
 
83 
 
 
 
Figure 4.3.1.2: Scanning electron micrographs of siRNA-functionalized 
calcium phosphate nanoparticles. A: Single-shell nanoparticles; B: Triple-shell 
nanoparticles.  
 
4.3.2 Gene silencing on HeLa-EGFP cells by siRNA-functionalized calcium 
phosphate nanoparticles 
For the gene silencing experiment we used two types of calcium 
phosphate/siRNA nanoparticles: Single-shell particles (core of calcium 
phosphate, shell of siRNA, described previously in Ref.
[91]
) and triple-shell 
particles (core of calcium phosphate, first shell of siRNA, second shell of 
calcium phosphate and outer shell of siRNA). In the latter case, siRNA was 
protected from degradation by intracellular endonucleases, which was 
previously proved to be efficient by Sokolova et al. for transfection with 
DNA.
[100]
 Nevertheless, as siRNA does not need to penetrate into the nucleus to 
exert its gene silencing activity but only needs to enter the cytoplasm, the 
protecting effect of the calcium phosphate layer in triple-shell particles must be 
only temporal and adjustable for the cytoplasmatic dissolution and release of 
siRNA.  
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As controls, we used cells transfected with siRNA alone (without any 
transfection reagent or carrier), cells transfected with siRNA by the standard 
calcium phosphate method,
[83]
 and the commercial transfection agent Polyfect
®
.  
 
 
Figure 4.3.2.1: Transmission light microscopy (top row) and EGFP 
fluorescence microscopy (bottom row) of HeLa-EGFP after transfection with 
siRNA for gene silencing. In the top row all cells can be seen. In the bottom 
row, the cells which still express EGFP appear green. In all cases, the 
transfection was carried out in DMEM medium with FCS. A: Control cells, 
incubated only with cell culture medium without transfection agent or siRNA; 
B: Cell culture after transfection with single-shell calcium phosphate 
nanoparticles; C: Cell culture after transfection with triple-shell calcium 
phosphate nanoparticles; D: Cells after transfection with the standard calcium 
phosphate precipitation method; E: Cell culture after transfection with the 
commercial transfection agent Polyfect
® 
(magnification 200x in all cases).  
 
Figure 4.3.2.1 shows micrographs of the transfection experiments (light 
microscopy and fluorescence microscopy). The extent of gene silencing can be 
easily computed from the ratio of the still fluorescing cells to the total number of 
cells. This method of course depends on the absolute number of cells within 
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each image. Nevertheless, these observations allow a preliminary 
characterization of the toxicity of the method and the cell vitality due to the 
changes in cell morphology (e.g. round and detached cells are damaged or 
already dead). However, such a calculation of the efficiency gives only relative 
values which are not comparable for different experiments because the 
percentage of green fluorescing cells in the control varies between the 
experiments (not every HeLa-EGFP cell shows the green fluorescence at the 
start of the experiment). Thus, the relative efficiency must be calculated as the 
ratio of the fluorescing cells after transfection to the ratio of the fluorescing cells 
of the control which was run simultaneously with each experiment. The typical 
percentage of green fluorescing cells in the control was 50 to 80 %, depending 
on the individual batch of cells. The efficiency of gene silencing is then 
expressed as 
 
(1) 
Figure 4.3.2.2 and Table 4.3.2.1 give the numerical results for all methods.  
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Figure 4.3.2.2: Relative efficiency of EGFP gene silencing on HeLa-EGFP 
cells. The diagram represents the average means ± standard deviation (*: 
P<0.001; **:  P<0.01).  
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Table 4.3.2.1: Results of the transfection experiments with HeLa-EGFP by 
numerical analysis of the fluorescence micrographs. The transfection efficiency 
is given as average ± standard deviation.  
Method Efficiency of  
gene silencing / % 
Control 0 
siRNA without calcium phosphate  4±22 
Single-shell calcium phosphate/siRNA nanoparticles  27±12 
Triple-shell calcium phosphate/siRNA nanoparticles  48±16 
Standard calcium phosphate precipitation method  21±8 
Transfection with Polyfect
®
 15±10 
 
The efficiency of gene silencing using the single- and triple-shell nanoparticles 
was 27 and 48 %, respectively. siRNA alone (without calcium phosphate as a 
carrier) showed almost no gene silencing effect (4±22 %), nevertheless 
indicating that siRNA alone can sometimes enter the cytosol. Single-shell 
nanoparticles, the standard calcium phosphate method and Polyfect
®
 did not 
show statistically significant differences in the efficiency of gene silencing. In 
contrast, the triple-shell nanoparticles were much more efficient, giving an 
efficiency of gene silencing of 48 % (and sometimes up to 64 %). 
We also investigated the influence of the concentrations of calcium and 
phosphate on the gene silencing efficiency. Here we used high concentrations of 
Ca
2+
 and PO4
3-
 (18 mM and 10.8 mM, respectively) and low concentrations 
(6.25 mM and 3.74 mM, respectively). In both cases the calcium/phosphate ratio 
corresponded to that of hydroxyapatite.  As shown in Figure 4.3.2.3, triple-shell 
nanoparticles showed no statistically significant differences in the efficiency if 
the calcium phosphate concentration was changed. The gene silencing efficiency 
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only slightly decreased from 61 to 53 %, but these changes are hardly to be 
considered. On the other hand, the efficiency of single-shell nanoparticles 
decreased from 50 to 28 % by using lower concentrations of calcium and 
phosphate (P<0.01).   
 
 
Figure 4.3.2.3: The influence of Ca
2+
- and PO4
3-
 concentrations on the gene 
silencing on HeLa-EGFP cells. 1: [Ca
2+
]=18 mM, [PO4
3-
]=10.8 mM; 2: 
[Ca
2+
]=6.25 mM, [PO4
3-
]=3.74 mM. 
 
In both cases we used an equal amount of siRNA for the functionalization of the 
nanoparticles and for the transfection. Presumably, the nucleic acid on 
nanoparticles maintains equilibrium between the dissolved nucleic acid and the 
acid adsorbed on the particle surface. Thus, the increase of calcium phosphate 
concentration leads only to the increase of the number of particles resulting in 
0
10
20
30
40
50
60
70
80
90
1 2
E
ff
ic
ie
n
cy
 o
f 
g
en
e 
si
le
n
ci
n
g
 /
 %
single-shell nanoparticles triple-shell nanoparticles
Anna Kovtun, Dissertation 2009 
 
89 
 
more efficient gene silencing with single-shell nanoparticles. The increase of the 
nanoparticle number increases the possibility for particles to reach the cytoplasm 
successfully and escape the degradation in the lysosomes. However, in triple-
shell particles the siRNA is already protected from the degradation by an 
additional shell of calcium phosphate, thus the number of particles is not so 
critical for the successful gene silencing and leads only to a minor and 
insignificant increase of the gene silencing efficiency. 
 
4.3.3 Conclusion 
In the present study we showed how to prepare calcium phosphate nanoparticles 
functionalized with siRNA as delivery system for efficient gene silencing. We 
prepared single- and triple-shell nanoparticles and tested them in vitro on HeLa-
EGFP cells for the down-regulation of the EGFP expression. The particles had a 
size around 200 nm with spherical morphology and negative zeta potential. 
These particles were easily taken up by cells by endocytosis. Moreover, in the 
case of triple shell nanoparticles the inner layer of siRNA is protected from the 
endosomal nucleases, thus resulting in far more effective silencing in cytosol. 
Single-shell nanoparticles showed an efficiency of gene silencing of around 
27 %, whereas triple shell nanoparticles had an efficiency of around 50 %.  
Thus, siRNA-functionalized calcium phosphate multi-shell nanoparticles 
represent a very effective delivery system showing many advantages over other 
non-viral and viral systems. They are not toxic for cells and highly 
biocompatible. Moreover, they can be easily and cost-effectively prepared, 
comparing with many other polymeric agents. The triple-shell particles even 
exceeded the efficiency of the classical transfection agent Polyfect
®
. 
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4.4 Calcium phosphate nanoparticles functionalized with shRNAs 
4.4.1 Synthesis and characterization of the nanoparticles functionalized 
with shRNAs 
We were already able to synthesize nanoparticles stabilized with DNA
[91]
 and 
siRNA.
[95]
 All these particles carry a negative charge due to the presence of 
negatively charged nucleic acids on their surface.  
In this study we prepared nanoparticles functionalized with small hairpin RNA 
(short hairpin RNA or shRNA). This name comes from its structure which 
makes a hairpin-like turn, thus providing a double-stranded structure, as shown 
in Figure 4.4.1.1.  
 
 
Figure 4.4.1.1: Schematic representation of shRNA structure. 
 
In shRNAs an oligonucleotide sequence containing the siRNA sequence is 
followed by a ~ 9-nucleotide (9-nt) loop and a reverse complement of the siRNA 
sequence.  It is usually introduced into cells in a viral vector or plasmid ensuring 
endogenous long-time expression of shRNA, which is subsequently processed in 
the cytoplasm by Dicer to siRNA and leads to gene silencing, either by inducing 
the sequence-specific degradation of complementary mRNA or by inhibiting 
translation.
[12,13,19]
 While the synthetic siRNA effects are short-lived probably 
because of siRNA dilution with cell division and also degradation, the shRNA 
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effects are lasting longer because siRNA is continually produced within the 
cells. 
The ultimate aim of this project was to produce shRNA-functionalized calcium 
phosphate nanoparticles and then embed them into polyelectrolyte multilayers 
using the layer-by-layer technique,
[146]
 thus localizing the application of the 
nanoparticles.
[147-149]
 The layer-by-layer buildup of polyelectrolyte multilayered 
films from oppositely charged polyelectrolytes offers new opportunities for the 
preparation of functionalized biomaterial coatings. This technique allows the 
preparation of supramolecular nanoarchitectures with the specific ability to 
control cell activation
[147]
 and may also play a role in the development of local 
drug delivery systems.
[150]
 
Rives et al. already used DNA encapsulating in PLGA (poly(lactide-co-
glycolide)) scaffolds for efficient in vivo gene delivery. They were able to 
transfect adipose tissue and macrophages.
[151]
  Lu et al. used the layer-by-layer 
technique to integrate DNA into layers of poly(2-aminoethyl propylene 
phosphate) on quartz substrate pre-coated with poly(ethylene imine) to achieve 
prolonged gene expression.
[152]
  
As model system, we synthesized multi-shell calcium phosphate/shRNA 
nanoparticles to observe their abilities to inhibit the osteopontin and osteocalcin 
expressions in human osteoblasts.
[153]
 These proteins play a central role in the 
mineralization and the remodeling of bone, thus maintaining the calcium ion 
homeostasis.
[154,155]
 
shRNA-functionalized calcium phosphate nanoparticles were prepared by rapid 
mixing of aqueous solutions of calcium and phosphate salts and subsequent 
functionalization of the precipitate with shRNA to prevent the aggregation of 
nanoparticles. We used two types of shRNA: Spp1 (81 bp) for silencing the 
osteopontin expression and Bglap-rs1 (70 bp) for silencing the osteocalcin 
expression. These nanoparticles consisted of a calcium phosphate core and an 
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outer layer of shRNA for electrostatic and steric functionalization (single-shell 
nanoparticles).  
In order to produce a multilayer structure we subsequently added to the mixture 
of the single-shell nanoparticles Ca(NO3)2 solution (6.25 mM) and (NH4)2HPO4 
solution (3.74 mM), and then 0.1 mg of shRNA for further functionalization of 
the particles. These particles consisted of the layers CaP – shRNA – CaP – 
shRNA and were named “triple-shell”. 
The characterization of the nanoparticles by scanning electron microscopy 
showed spherical particles with a particle size from 100 nm up to 250 nm, both 
for single- and triple-shell nanoparticles functionalized with Spp1 and 80-
200 nm for the nanoparticles functionalized with Bglap-rs1 (Figures 4.4.1.2 and 
4.4.1.3).  
 
 
Figure 4.4.1.2: Scanning electron micrographs of calcium phosphate 
nanoparticles functionalized with shRNA against osteopontin (Spp1). A: single-
shell nanoparticles; B: triple-shell nanoparticles. 
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Figure 4.4.1.3: Scanning electron micrographs of calcium phosphate 
nanoparticles functionalized with shRNA against osteocalcin (Bglap-rs1). A: 
single-shell nanoparticles; B: triple-shell nanoparticles. 
 
The dynamic light scattering of the nanoparticles was complicated due to very 
small amounts of the samples and, therefore, their strong dilution. However, 
peaks in the range of 110-220 nm were always present. In addition, the particles 
showed a negative zeta potential. 
 
4.4.2 Gene silencing using calcium phosphate nanoparticles functionalized 
with shRNAs 
The tests of the nanoparticles in cell culture were performed at the group of Dr. 
Nadia Benkirane-Jessel at the Institut National de la Santé et de la Recherche 
Médicale in Strasbourg, France. 
First, the biological activities of nanoparticles were tested by the production of 
osteopontin and osteocalcin in the human osteoblasts (HOb) which were brought 
into contact with dispersions of nanoparticles. The cells grew in Osteoblast 
Growth Medium at 37 ºC in humidified atmosphere with 5 % CO2. 
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Different controls were performed: Untreated cells which were incubated only in 
cell culture medium; cells incubated with calcium phosphate/pcDNA3-EGFP 
nanoparticles (single- and triple-shell, 8 µg calcium phosphate were used per 
well); HOb cells incubated in medium containing free Spp1 or Bglap-rs1 and 
cells transfected with Spp1 and Bgrap-rs1 using commercial multicomponent 
reagent FuGENE
®
. 
We incubated the cells with the transfection medium for 21 days replacing the 
medium every 3 days with the fresh transfection medium. Then the cells were 
fixed with 2 % paraformaldehyde in phosphate buffered saline solution (PBS). 
The protein expression in HOb cells was detected by immunofluorescence. The 
cells were incubated overnight at room temperature with goat anti-osteopontin 
or osteocalcin antibody as primary antibody and then washed with PBS 
containing 0.1 % Triton X-100 and incubated with a donkey anti-goat antibody 
as secondary antibody for 1 h at room temperature. The nuclei were visualized 
by Hoechst 33258 staining. Here the cell nuclei are visualized in blue to detect 
the general number of cells per image, and red color represents osteopontin or 
osteocalcin, respectively. The results of the experiments are shown in the Figure 
4.4.2.1. 
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Figure 4.4.2.1: Gene silencing on human osteoblasts using calcium phosphate 
nanoparticles functionalized with shRNA against osteopontin (Spp1) and 
osteocalcin (Bglap-rs1) after 21 days of transfection from the suspension. Top 
row: Cells transfected with Spp1 shRNA by different ways; middle row: Cells 
transfected with Bglap-rs1 shRNA by different ways; bottom row: Control 
cells. 
 
A high level of expression of osteopontin and osteocalcin was detected in the 
control osteoblasts incubated only in the cell culture medium and in the cells 
transfected with calcium phosphate/pcDNA3-nanoparticles (Figure 4.4.2.1, 
bottom row). We detected the red fluorescence of almost the whole cell 
cytoplasm. The protein expression was only slightly inhibited in the cells 
incubated in the presence of free Spp1 and Bglap-rs1 and partially inhibited in 
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the cells transfected with FuGENE
®
.  In this case we observed some expression 
but not very high and only as local islands and not in the whole cytoplasm.  
However, the expression of desired proteins was almost fully inhibited using 
single- and triple-shell calcium phosphate/shRNA nanoparticles. We observed 
no red fluorescence of desired proteins after gene silencing with both types of 
particles. 
The next step was to introduce the nanoparticles into the layers using the layer-
by-layer technique to achieve a local particle application and the gradual release 
of the particles from the layers and, thus, the gradual transfection of the cells to 
balance the loss of nucleic acid by metabolic degradation.
[156]
  
Jewell et al. already showed that multilayered films consisted of pDNA and a 
polyamine are able to release pDNA from the surfaces under physiological 
conditions for transfection of adherent cells.
[157,158]
 They suggested that the films 
present DNA in a condensed form which improved the internalization of DNA 
by cells. Rives and co-workers also encapsulated DNA in PLGA scaffolds for 
efficient in vivo gene delivery.
[151]
   
For the formation of multilayer films we used triple-shell nanoparticles, which 
showed the best results in the previous experiment. We produced multilayer 
films consisting of nanoparticles and cationic polymer poly-(L-lysine) (PLL) for 
locally defined and temporarily variable gene silencing. The chemical structure 
of PLL is shown in Figure 4.4.2.2. 
 
 
Figure 4.4.2.2: Chemical structure of poly-(L-lysine). 
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The layers were prepared according to standard procedure, as described in 
Ref.
[147]
 
To test the gene silencing abilities of the nanoparticles embedded in the 
multilayer system, the HOb cells were seeded on (PLL-nanoparticles)1 (one 
bilayer) and (PLL-nanoparticles)6 multilayer films (six bilayers; PLL as bottom 
layer, nanoparticles as upper layer)  and incubated for 21 days. The results are 
shown in Figure 4.4.2.3.  
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Figure 4.4.2.3: Gene silencing on human osteoblasts after 21 days of 
transfection with different transfection methods: with triple-shell calcium 
phosphate nanoparticles from dispersion and from multilayer films prepared by 
layer-by-layer technique with shRNA-functionalized calcium phosphate 
nanoparticles. Top row: Cells transfected with Spp1 shRNA by different ways; 
middle row: Cells transfected with Bglap-rs1 shRNA by different ways; 
bottom row: Control cells. 
 
Our results clearly indicated that when incorporated into the multilayered film, 
the shRNA nanoparticles induced a much stronger specific inhibition of the 
expressions of target proteins than the same nanoparticles used as dispersions or 
naked Spp1 and Bglap-rs1 in the solution (Figure 4.4.2.3). In the latter case the 
expression of osteopontin and osteocalcin was still present and almost as strong 
as in the control cells.  
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The “normal” osteopontin or osteocalcin expression was detected in untreated 
cells HOb cells and in cells treated with the solutions of free shRNAs (Spp1 and 
Bglap-rs1, respectively). Nevertheless, the cells transfected with the 
nanoparticles from the dispersion show a significant decrease of the osteopontin 
and osteocalcin expression. Moreover, when the particles were embedded in the 
multilayered film consisted of one bilayer (PLL-nanoparticles)1, the gene 
expressions of osteopontin and osteocalcin were inhibited slightly more than 
those in dispersion. Furthermore, in the case of film consisted of six bilayers 
(PLL-nanoparticles)6, the gene expressions of both osteopontin and osteocalcin 
were both drastically inhibited. There no red fluorescence of desired proteins 
was detected. Thus, the best gene silencing was obtained with triple-shell 
shRNA-functionalized nanoparticles embedded in six bilayers.  
 
4.4.3 Conclusion 
We reported here the first application of a multilayered films-based delivery 
system containing shRNA-functionalized nanoparticles for gene silencing of 
osteopontin and osteocalcin which are specific for bone cells. The nanoparticles 
had a size up to 250 nm and a negative zeta potential. shRNA-functionalized 
nanoparticles were effectively embedded into the PLL multilayers and used for 
local gene silencing of osteopontin and osteocalcin in human osteoblasts. The 
expressions of proteins were effectively inhibited both in the case of transfection 
from a dispersion or from the (PLL-nanoparticles)n multilayer films. However, 
gene silencing from the films consisted of six bilayers was most efficient. 
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4.5 Functionalization of nanoparticles with oligonucleotides for the 
activation of dendritic cells 
4.5.1 Synthesis and characterization of the nanoparticles functionalized 
with Poly(I:C) and CpG 
In our previous work (Sections 4.3 and 4.4) we were able to show that it is 
possible to stabilize calcium phosphate nanoparticles with oligonucleotides. 
Sokolova et al. prepared nanoparticles functionalized with single- and double-
stranded oligonucleotides of different length.
[95]
 Although the optimal 
concentration was different, the binding occurs presumably by interaction of the 
negatively-charged phosphate groups of nucleic acids and positively-charged 
calcium ions. Thus, the interaction is not specific and depends only on the 
conformation of phosphate backbone. Therefore, the concentration of 
oligonucleotides needed for the stabilization of nanoparticles does not depend on 
the length of the oligonucleotides, but highly depends on the conformation of 
nucleic acid, i.e. whether it is single- or double-stranded.   
The aim of the present research was to functionalize the calcium phosphate 
nanoparticles with oligonucleotides able to activate the immune system.  We 
chose two different oligonucleotides: CpG and Poly(I:C). 
CpG (cytosin-phosphatidyl-guanosin) islands are genomic regions with an 
increased density of C and G nucleotides. They are able to mimic the ability of 
microbial DNA to activate the innate immune system.
[27,28,30-33]
  
Poly(I:C) (polyinosinic-polycytidylic acid, double-stranded homopolymer) 
sequences are synthetic analogues of double-stranded RNAs associated with 
viral infection. They can also induce an immune response and are used for the 
generation of mature dendritic cells.
[34,35]
 
Our aim was to use both CpG (sequence: 5´-TCC ATG ACG TTC CTG ACG 
TT-3´, 6364 g mol
-1
) and Poly(I:C) for the maturation of dendritic cells (DC), 
thus breaking the tolerance and activating the immune system against previously 
undetectable antigens.
[36]
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The synthesis of nanoparticles was performed as follows: The solutions of 
calcium nitrate and diammonium hydrogen phosphate were adjusted to pH 9 
with 0.1 M NaOH and then mixed with a peristaltic pump. Immediately 
afterwards the dispersion was functionalized with 167 µL CpG (63 µM) or a 
mixture of 2.5 µL CpG (63 µM) and 198 µL Poly(I:C) (1 mg mL
-1
). The 
obtained nanoparticles were characterized using scanning electron microscopy 
(Figure 4.5.1.1) and dynamic light scattering.  
 
 
Figure 4.5.1.1: Scanning electron micrographs of calcium phosphate 
nanoparticles functionalized with CpG and Poly(I:C) oligonucleotides. 
 
The nanoparticles with CpG had a size around 70 nm and spherical morphology. 
The nanoparticles functionalized with CpG and Poly(I:C) were also spherical, 
but had a size around 120 nm.  
DLS measurements showed that calcium phosphate/CpG nanoparticles had a 
size around 282 nm and a zeta potential of -19 mV (PDI=0.5), whereas calcium 
phosphate/CpG/Poly(I:C) nanoparticles had a diameter of 350 nm with a zeta 
potential of -17 mV (PDI=0.3).  However, due to the small amount of material 
and therefore their strong dilution it was difficult to obtain better results. 
Anna Kovtun, Dissertation 2009 
 
102 
 
Moreover, the DLS measurements showed only the hydrodynamic radius of the 
particles.   
 
4.5.2 Activation of dendritic cells using nanoparticles functionalized with 
Poly(I:C) and CpG  
The cell experiments were performed by Dr. Mathias Krummen from the 
University of Münster.  
In these experiments we used pure solutions of calcium nitrate (6.25 mM) 
diammonium hydrogen phosphate (3.74 mM) and their mixture, and CpG 
solution (63 µM) as controls. We also centrifuged the dispersion of the 
nanoparticles for 2 h at 40,000x g to find out whether the supernatant still 
contained free CpG molecules.   
The efficiency of the delivery of CpG and Poly(I:C) was detected by the release 
of interleukin 12 (IL-12), a cytokine with many functions in the immune system.  
As shown in Figure 4.5.2.1, almost no effect was observed after the addition of 
pure Ca
2+
 or PO4
3-
 solutions to the dendritic cells (DC) or their mixture. This 
effect was comparative to the activity of control (untreated) cells and was 
between 0 and 20 pg mL
-1
. A moderate effect (about 76 pg of IL-12 per mL) was 
observed after the incubation of cells with free CpG or the supernatant of the 
nanoparticles, thus confirming that the dispersion of the nanoparticles still 
contained free CpG molecules which were not adsorbed on the particle surface. 
However, it was not possible to obtain stable particles by functionalizing them 
with smaller amounts of CpG. This indicates that the equilibrium between free 
and adsorbed CpG is essential for the functionalization of the particles.   
However, the effect detected after the incubation of the nanoparticles with DC 
was almost two times higher, i.e. around 170 pg mL
-1
. 
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Figure 4.5.2.1: The release of IL-12 by dendritic cells after the activation with calcium phosphate nanoparticles 
functionalized with CpG. [Ca
2+
] =6.25 mM, [PO4
3-
]=3.74 mM, [CpG]=0.063 mM. An arrow indicates release of IL-12 from 
the DC after the stimulation with calcium salt solution (0 pg mL
-1
). 
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To check whether the stimulation of DC was so efficient due to the 
nanoparticles, we performed experiment with a further control. We compared 
the nanoparticle activity compared to the precipitate of particles obtained in situ 
using mixture of inorganic salts ([Ca
2+
]=6.25 mM  and  [PO4
3-
]=3.74 mM) and 
CpG, which approximately corresponds to the standard precipitation method of 
Graham and van der Eb.
[83]
 In the latter case calcium phosphate/CpG particles 
are built up spontaneously and are polydisperse, i.e. we have microparticles as 
well as nanoparticles. The observed results are shown in Figure 4.5.2.2. 
Moreover, it was already described that calcium phosphate precipitates can 
increase gene expression in DC. 
[36]
 
 
 
Figure 4.5.2.2: The release of IL-12 by dendritic cells after the activation using 
calcium phosphate nanoparticles functionalized with CpG and after precipitation 
of particles in situ. 
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The cells treated with calcium phosphate/CpG nanoparticles or in situ 
synthesized particles from the mixture of calcium and phosphate salt solutions 
and CpG solution showed an equally high release of the IL-12 – around 
250 pg mL
-1
.  
We can conclude that the activation of DC (and therefore the release of IL-12) 
occurred due to the uptake of the calcium phosphate/CpG particles, but not due 
to the presence of free CpG or inorganic ions in cell culture medium.  Moreover, 
this stimulation effect did not depend on the synthesis method; the results 
obtained after controlled precipitation of the particles and after synthesis in situ 
were equal and led to the 2 times higher release of IL-12. However, the method 
of particles synthesis can be very important for further experiments, e.g. for 
further functionalization of particles by antibodies or markers. Therefore, the 
controlled synthesis of particles is preferred. 
 
4.5.3 Conclusion 
Calcium phosphate nanoparticles were functionalized with nucleic acids not 
only for transfection, but also for the activation of dendritic cells. Such particles 
appear to be an effective matrix for the delivery of maturation signals into the 
dendritic cells. The maturation of the cells was detected by the release of IL-12. 
The efficiency of the nanoparticles was 2.5 times higher than the effect of free 
CpG solution.  
These results provide us with a diversity of applications of the nanoparticles 
functionalized with different nucleic acids both in vitro and in vivo. We were 
able to deliver not only specific genes or gene‟s inhibitors into the cells, but 
differentiation signals while still maintaining low toxicity. 
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4.6 Surface-mediated transfection with DNA-functionalized calcium 
phosphate nanoparticles  
4.6.1 Preparation of electrophoretically coated titanium substrates 
The coatings were partially prepared by Dr. Henning Urch and Dipl.-Chem. 
Manuel Neumeier in our group.  
All previously discussed delivery systems come as dispersions and have to be 
administered into the desired tissue or given systemically. Even if a delivery 
system has high transfection efficiency, there still remains the question of the 
local application of therapeutic agent. Thus, materials that provide spatial and 
temporal control over the DNA delivery play an important role in localized 
nucleic acid-based therapies. 
Usually such delivery systems consist of DNA embedded into polyelectrolyte 
layers. One can use poly(ethylene imine) and poly(allylamine 
hydrochloride),
[159]
 poly-L-lysine,
[160]
 poly(2-aminoethyl propylene 
phosphate)
[152]
 and poly(L-tartaramido pentaethylene tetramine).
[161]
 DNA can 
also be encapsulated into porous PLGA scaffolds. Such scaffolds were already 
shown to be effective in vivo by Rives et al.
[151]
 
However, the main disadvantage of all these techniques is an application of 
synthetic polymers which, after the degradation in the organism, may be toxic.  
We were able to produce bioactive metal surfaces coated with calcium 
phosphate nanoparticles via electrophoretic deposition.  
A conducting surface of any shape can be electrophoretically coated with DNA-
loaded calcium phosphate nanoparticles if these particles are transferred into 2-
propanol or ethanol to avoid the electrolytic decomposition of water. Multilayers 
of nanoparticles with a thickness of a few µm were prepared.
[162]
 As substrate 
we used titanium plates with a size of 10·10 mm. Unfortunately, it was 
impossible to produce thin and smooth coatings with calcium phosphate/DNA 
nanoparticles alone. Therefore, we prepared calcium phosphate nanoparticles 
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functionalized with poly(ethylene imine) (PEI) which were coated in a second 
step with DNA. This system gave an excellent smooth coating of the titanium 
surfaces. Electrophoretic coating was carried out at a voltage of 50 V for 30 s, 
giving a layer thickness of about 1 µm.  A schematic setup of the electrophoresis 
apparatus is shown in Figure 4.6.1.1. 
 
 
Figure 4.6.1.1: Scheme (A) and photograph (B) of the electrophoresis setup. 
 
The nanoparticles were prepared by precipitation of calcium phosphate/PEI 
nanoparticles, their redispersion in 2-propanol
[162,163]
 and the addition of another 
layer of the plasmid DNA (pcDNA3-EGFP). Dynamic light scattering of the 
particles gave a size of the calcium phosphate/PEI nanoparticles of 149 nm and 
a zeta potential of +38 mV.
[164]
 Scanning electron micrographs (SEM) showed a 
thin and smooth layer of nanoparticles on the metal surface with a thickness of 
about 1 µm as shown in Figure 4.6.1.2. 
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Figure 4.6.1.2: Scanning electron micrograph of the titanium substrate coated 
with calcium phosphate/PEI/DNA nanoparticles.
[164]
 
 
4.6.2 Surface-mediated transfection of cells  
After the successful deposition of nanoparticles on metal surface we tested this 
delivery system in the cell culture. Fibroblasts (NIH3T3) were cultivated on 
titanium plates coated with pcDNA3-EGFP/PEI-functionalized nanoparticles. 
Titanium was used as typical implant material. The efficiency of transfection 
was monitored by the expression of the characteristic green fluorescence of 
EGFP. In a 24-well plate, 5·10
4
 cells per well were seeded on coated titanium 
plates in growth medium (RPMI 1640 supplemented with 10 % FCS, 2 mM 
glutamine, 100 U mL
-1
 penicillin, 100 µg mL
-1
 streptomycin) and incubated at 
37 °C in humidified atmosphere with 5 % CO2. After 7 h the incubation medium 
was replaced with the fresh medium to remove the nanoparticles which had been 
detached from the metallic substrate and dispersed in the medium. 
As control we used the following systems:  
1. Cells cultivated on pure titanium plates;  
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2. Cells cultivated on pure titanium plates and transfected with the 
commercial agent Polyfect
®
 from the dispersion;  
3. Cells cultivated on calcium phosphate/PEI nanoparticle-coated plates;  
4. Cells cultivated on calcium phosphate/PEI nanoparticle-coated surface 
with DNA which was dripped onto the coating and dried at 37 ºC before 
seeding of the cells.  
The schematic representation of the experiment and one of the controls is shown 
in Figure 4.6.2.1. 
 
 
Figure 4.6.2.1: Schematic representation of the coating of the titanium surface 
with (A) calcium phosphate/PEI/DNA and (B) calcium phosphate/PEI 
nanoparticles with subsequent addition of DNA solution and the subsequent 
transfection. 
 
First we analyzed the cytocompatibility of the coatings and the attachment of 
cells to the surface by scanning electron microscopy. The cells were cultivated 
on coated titanium plates for 48 h, then fixed with 3% paraformaldehyde, 
dehydrated in an ascending ethanol row (20, 40, 60, 80 and 96 %) and then 
subjected to critical point drying. A morphological analysis of the cell culture by 
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SEM showed an excellent adhesion of the cells to the substrate and also a large 
number of nanoparticles on the cell surface (Figure 4.6.2.2). The nanoparticles 
were found also on the upper side of cells presumably due to the special method 
of cell locomotion on the coating. Such a tight contact of the cell membrane 
with a large number of particles enhances the chance of the nanoparticles to be 
taken up via endocytosis, in contrast to the usual methods where dispersed 
nanoparticles are used which only rarely meet the cell surface. Also, the 
spreading of the cells on the coating and their good adhesion indicated that cells 
remained healthy.  
 
 
Figure 4.62.2.2: Scanning electron micrograph of NIH3T3 fibroblasts grown on 
calcium phosphate/PEI/DNA nanoparticle-loaded titanium surfaces. Top row: 
Cells seeded on the calcium phosphate/PEI/DNA nanoparticle coating; bottom 
row: Cells seeded on the calcium phosphate/PEI nanoparticle coating with 
dripped DNA.  Yellow arrows indicate nanoparticles on the cell surface. 
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Therefore, we subjected the cells to the further incubation and measured the 
transfection efficiency. After 48 h of incubation, we observed a successful 
transfection by fluorescence microscopy, flow cytometry (fluorescence-
activated cell sorting, FACS) and Western Blot. The cell nuclei were 
additionally stained with DAPI (4',6-diamidino-2-phenylindole, a fluorescent 
dye, which strongly binds to DNA) to detect the general number of cells on the 
substrate in comparison to the green fluorescing cells. The results of reflected-
light fluorescence microscopy are shown in Figure 4.6.2.3.  
 
Anna Kovtun, Dissertation 2009 
 
112 
 
 
Figure 4.6.2.3: Fluorescence microscopy of NIH3T3 cells seeded on coated 
titanium surfaces, cells seeded on titanium and transfected from dispersion and 
of cells transfected with Polyfect
®
. Transfected cells are green due to the 
expression of EGFP.  Upper row: Cell nuclei stained with DAPI; middle row: 
Cells expressing EGFP; bottom row: Overlay of both images (magnification: 
200x in all cases). 
 
Figure 4.6.2.3 shows the general number of cells on the plate (all living cell 
nuclei were stained blue with DAPI) and successfully transfected cells (green 
due to the expression of EGFP). However, due to the strong autofluorescence of 
the cells and the fluorescence of the coating (particularly in Figure 4.6.2.3, first 
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column), the numerical analysis of the micrographs was not possible. Therefore, 
we performed flow cytometry of the samples. The graphical results of the FACS 
analysis are shown in Figures 4.6.2.4-4.6.2.5 and the numerical results are 
presented in Table 4.6.2.1. 
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Figure 4.6.2.4: Flow cytometry of control NIH3T3 cells seeded on titanium 
surface (A) and cells seeded on the titanium plates and transfected with 
Polyfect
®
 from dispersion (B).  
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Figure 4.6.2.5: Flow cytometry of NIH3T3 cells transfected with calcium 
phosphate/PEI nanoparticles with later dripped DNA from the coating (A) and 
cells transfected with calcium phosphate/PEI/DNA nanoparticles from the 
coating (B).  
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NIH3T3 cells seeded on titanium substrate were used as a standard for the living 
population and as a negative control for the EGFP transfection efficiency 
(Figure 4.6.2.4, A). The living population was defined and gated according to 
the FSC/SSC parameters (Forward Scatter or FSC, a detector in line with the 
light beam and Side Scatter or SSC, a detector perpendicular to the light beam) 
individually for each set of experiments. The region with living cells was 
analyzed by dot plot analysis using two parameters: FSC and EGFP 
fluorescence intensity. The square statistics were used to analyse single positive 
(only on one axis) and double positive (on both axes) cells. Alive cells were 
selected according to their granularity, gated in the left upper square and were 
assumed to be EGFP negative. The gate for EGFP was set up according to this 
population and all samples were analyzed accordingly to this square statistics. 
The background in the negative control (NIH3T3 cells seeded on titanium 
substrate) was around 2 %. Presumably these were dust particles or impurities in 
dispersion. The cells transfected with Polyfect
®
 showed a moderate transfection 
efficiency of about 16.8 %. Cells seeded on titanium substrate coated with 
calcium phosphate/PEI/DNA and calcium phosphate/PEI nanoparticles with 
dripped DNA showed a similar transfection efficiency of 14.5 and 16.3 %, 
respectively.  
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Table 4.6.2.1: Efficiency of gene transfer as determined by FACS (N=3). 
Sample Efficiency ± SD / % 
Control cells on titanium plates 2.4 ± 0.3 
CaP/PEI/DNA-nanoparticle coating  14.5 ± 5.1 
CaP/PEI-nanoparticles coating with dripped DNA  16.3 ± 8.8 
CaP/PEI nanoparticle coating 5.8 ± 2.9 
Polyfect
®
 as dispersion 16.8 ± 11.8 
 
To be entirely sure that observed fluorescence belonged to EGFP we performed 
Western Blot analysis of all samples. The results are shown in Figure 4.6.2.6. 
5·10
4
 cells were initially seeded per well, therefore Western Blotting was 
complicated due to the small amount of protein.  Anti-GFP, N-terminal primary 
antibody produced in rabbit
[165,166]
 was used to compare the levels of EGFP 
expression. Tubulin was used as loading control and detected using monoclonal 
mouse anti-tubulin antibody.
[167]
  
According to the loading of the equal amount of the total protein per well during 
the SDS-gel running procedure, we found the same amounts of tubulin by 
Western Blotting in all samples including the untransfected negative control. 
Thus, we observed bands of tubulin as loading control in the sample. The bands 
of EGFP were clearly seen in all cases.  
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Figure 4.6.2.6: Western Blot of NIH3T3 cells after transfection with different 
techniques. A: Cells onto calcium phosphate/PEI nanoparticle-coating with later 
dripped DNA; B: cells onto calcium phosphate/PEI/DNA nanoparticle-coating; 
C: Polyfect
®
 in dispersion; D: control untransfected cells.  
 
However, the amount of EGFP was different in each case. We could clearly 
observe the strongest band in the case of cells transfected with calcium 
phosphate/PEI nanoparticles with later dripped DNA and in the case of calcium 
phosphate/PEI/DNA nanoparticles. Using Polyfect
®
 we also detected EGFP 
expression; however, in this case the level of expression was slightly lower. 
These data correspond to the results previously obtained by FACS analysis and 
reflected-light fluorescence microscopy.  
Thus, such a localized application of calcium phosphate nanoparticles leads to a 
successful transfection of cells and can be further applied in vivo. The coating of 
implants with transfection agents helps to avoid the systemic application of gene 
carriers and therefore to minimize the side effects of such application. For 
example, calcium as one of the important intracellular ions is involved in muscle 
contraction or intracellular signaling pathways. Thus, the increase of calcium 
concentration in bloodstream can lead to, e.g., formation of atherosclerotic 
plaques, or cell death due to the disturbance of intracellular ionic balance, as 
shown in Section 4.2. Therefore, the localized therapy of local tissue is very 
promising.  
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4.6.3 Conclusion 
We developed an easy method of electrophoretic deposition of DNA-loaded 
calcium phosphate nanoparticles on conducting implants which could be used 
for an efficient gene therapy. The addition of PEI as a first step of particle 
functionalization considerably improved the structure of nanoparticle layer.  
The transfection efficiency of such coatings on NIH3T3 cells was comparable to 
that of commercial reagent Polyfect
®
 and probably achieved due to the 
locomotion of the cells on the substrate which leads to a greater and tighter 
surface contact of cells with many nanoparticles, thereby enhancing the chance 
of particles to penetrate the cell membrane. Fluorescent reflected-light 
microscopy, flow cytometry and Western Blotting showed that cells expressed 
EGFP after 48 h cultivation on the nanoparticle-coated titanium substrate. The 
electrophoretic deposition of functionalized nanoparticles on any conducting 
material offers a way for the localized gene therapy avoiding long circulation of 
therapeutic agent in blood and, therefore, possibly minimizing the side effects 
on the organism due to the presence foreign agents (i.e. calcium phosphate 
nanoparticles).  
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5 Summary 
In this study chemical, biological and biochemical investigations were carried 
out in collaboration with our partners: The Chair of Molecular 
Neurobiochemistry at the Ruhr-University of Bochum, the Department of 
Dermatology at the University of Münster and the Institut National de la Santé 
et de la Recherche Médicale at the Université Louis Pasteur, Strasbourg, France. 
The main purpose of these collaborations was to apply calcium phosphate 
nanoparticles as carriers for nucleic acids into different cell systems to test its 
properties.  
First, we performed an easy and straightforward synthesis of calcium phosphate 
nanoparticles partially or completely substituted by magnesium or aluminum. 
However, although these nanoparticles were much smaller than the pure calcium 
phosphate nanoparticles, they did not prove to be very efficient for the delivery 
of nucleic acids.  
In order to test the toxicity of the system we monitored the intracellular calcium 
level by using of 
45
Ca-marked nanoparticles and the calcium dye Fura-2. Our 
nanoparticulate delivery system proved to be nontoxic to the cells compared to 
other delivery systems (the commercial agent Polyfect
®
 and the standard 
calcium-based method). Nanoparticles also did not lead to the disturbances of 
the intracellular calcium level which, otherwise, could be lethal for cells.  
In the next steps we functionalized the calcium phosphate nanoparticles with 
different oligonucleotides and tested them on cell culture. The nanoparticles 
functionalized with siRNA were far more effective than Polyfect
®
 and still 
nontoxic. The nanoparticles functionalized with shRNA effectively inhibited the 
synthesis of osteopontin and osteocalcin when also embedded into 
polyelectrolyte multilayers. This also allows the localized application of gene 
silencing.  
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We functionalized the nanoparticles with the oligonucleotides which are able to 
mimic the microbial antigens, thus activating the immune system and breaking 
the innate tolerance of the organism. We used CpG oligonucleotides for the 
activation of the dendritic cells which leads to the synthesis of IL-12 and 
presumably other signaling molecules.  
We performed localized transfection experiments via deposition of the 
nanoparticles on metal substrates. In this case we could achieve high 
transfection efficiency and a local direct application. 
Thus, we showed that the synthesis of calcium phosphate nanoprecipitates and 
their subsequent functionalization is possible. Such system was effectively used 
as a carrier for DNA and RNAs into the different cell cultures and proved to be 
effective and nontoxic for cells.  
  
Anna Kovtun, Dissertation 2009 
 
122 
 
6 Literature 
[1] J. D. Watson, F. H. C. Crick, Nature, 171, (1953), 737. 
[2] M. Feughelman, R. Langridge, W. E. Seeds, A. R. Stokes, H. R. Wilson, 
C. W. Hooper, M. H. F. Wilkins, R. K. Barclay, L. D. Hamilton, Nature, 
175, (1955), 834  
[3] D. M. Crothers, V. A. Bloomfield, I. Tinoco, Nucleic acids: Structures, 
properties, and functions, University Science Books, (2000). 
[4] J. D. Watson, F. H. C. Crick, Am. J. Psychiatr., 160, (2003), 623. 
[5] J. Iball, H. R. Wilson, Nature, 198, (1963), 1193. 
[6] G. M. Blackburn, M. J. Gait, D. Loakes, Nucleic acids in chemistry and 
biology, 3 ed., RSC Publishing, (2005). 
[7] J. D. Brown, M. Lyall, Aust. J. Chem., 15, (1962), 851. 
[8] P. E. Squires, R. F. L. James, N. J. M. London, M. J. Dunne, Pflügers 
Archiv  Eur. J. Physiol., 427, (1994), 181. 
[9] G. E. Billman, Cardiovasc. Res., 28, (1994), 762. 
[10] R. F. Gesteland, J. F. Atkins, T. R. Cech, The RNA world: The nature of 
modern RNA suggests a prebiotic RNA, 2 ed., CSHL Press, (1999). 
[11] R. W. Holley, J. Apgar, G. A. Everett, J. T. Madison, M. Marquisee, S. H. 
Merrill, J. R. Penswick, A. Zamir, Science, 147, (1965), 1462. 
[12] A. Z. Fire, Angew. Chem. Int. Ed., 46, (2007), 6966. 
[13] C. C. Mello, Angew. Chem. Int. Ed., 46, (2007), 6985. 
[14] J. Kurreck, Angew. Chem., 121, (2009), 1404. 
[15] E. J. Sontheimer, R. W. Carthew, Cell, 122, (2005), 9. 
[16] F. Crick, Nature, 227, (1970), 561. 
[17] A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, C. C. 
Mello, Nature, 391, (1998), 806. 
[18] L. Gitlin, R. Andino, J. Virol., 77, (2003), 7159. 
[19] C. C. Mello, D. Conte Jr., Nature, 431, (2004), 338. 
Anna Kovtun, Dissertation 2009 
 
123 
 
[20] G. Meister, T. Tuschl, Nature, 431, (2004), 343. 
[21] J. Martinez, A. Patkaniowska, H. Urlaub, R. Lührmann, T. Tuschl, Cell, 
110, (2002), 563. 
[22] S. K. Radhakrishnan, T. J. Layden, A. L. Gartel, Virology, 323, (2004), 
173. 
[23] R. Lu, M. Maduro, F. Li, H. Li, G. Broitman-Maduro, W. Li, S. Ding, 
Nature, 436, (2005). 
[24] S. M. Elbashir, J. Harborth, K. Weber, T. Tuschl, Methods, 26, (2002), 
199. 
[25] R. Wadhwa, S. C. Kaul, M. Miyagishi, K. Taira, Mutat. Res. Fund. Mol. 
Mech. Mutagen., 567, (2004), 71. 
[26] D. Ovcharenko, R. Jarvis, S. Hunicke-Smith, K. Kelnar, D. Brown, RNA, 
11, (2005), 985. 
[27] M. Kerkmann, D. Lochmann, J. Weyermann, A. Marschner, H. Poeck, M. 
Wagner, J. Battiany, A. Zimmer, S. Endres, G. Hartmann, 
Oligonucleotides, 16, (2006), 313. 
[28] Y. Krishnamachari, A. K. Salem, Adv. Drug Deliv. Rev., 61, (2009), 205. 
[29] M. J. Heffernan, S. P. Kasturi, S. C. Yang, B. Pulendran, N. Murthy, 
Biomaterials, 30, (2009), 910. 
[30] G. Mutwiri, S. van Drunen Littel-van den Hurk, L. A. Babiuk, Adv. Drug 
Deliv. Rev., 61, (2009), 226. 
[31] N. Bessis, F. J. Garcia Cozar, M. C. Boissier, Gene Ther., 11, (2004), 
S10. 
[32] D. Verthelyi, D. M. Klinman, Clin. Immunol., 109, (2003), 64. 
[33] J. A. Aebig, G. E. D. Mullen, G. Dobrescu, K. Rausch, L. Lambert, O. 
Ajose-Popoola, C. A. Long, A. Saul, A. P. Miles, J. Immunol. Meth., 323, 
(2007), 139. 
Anna Kovtun, Dissertation 2009 
 
124 
 
[34] R. Spisek, J. Brazova, D. Rozkova, K. Zapletalova, A. Sediva, J. 
Bartunkova, Vaccine, 22, (2004), 2761. 
[35] C. Wischke, J. Zimmermann, B. Wessinger, A. Schendler, H. H. Borchert, 
J. H. Peters, T. Nesselhut, D. R. Lorenzen, Int. J. Pharm., 365, (2009), 61. 
[36] M. P. Seiler, S. Gottschalk, V. Cerullo, M. Ratnayake, V. P. Mane, C. 
Clarke, D. J. Palmer, P. Ng, C. M. Rooney, B. Lee, Mol. Ther., 15, 
(2007), 386. 
[37] J. R. Kovacs, Y. Zheng, H. Shen, W. S. Meng, Biomaterials, 26, (2005), 
6754. 
[38] E. Orrantia, P. L. Chang, Exp. Cell. Res., 190, (1990), 170. 
[39] P. Batard, M. Jordan, F. Wurm, Gene, 270, (2001), 61. 
[40] V. Sokolova, M. Epple, Angew. Chem. Int. Ed., 47, (2008), 1382. 
[41] D. T. Curiel, S. Agarwal, E. Wagner, M. Cotton, Proc. Natl. Acad. Sci. 
USA, 88, (1991), 8850. 
[42] J. H. Lee, M. J. Welsh, Gene Ther., 6, (1999), 676. 
[43] S. K. Tripathy, H. B. Black, E. Goldwasser, J. M. Leiden, Nat. Med., 2, 
(1996), 545. 
[44] N. Ishii, J. Fukushima, T. Kaneko, E. Okada, K. Tani, S. I. Takana, AIDS 
Res. Hum. Retroviruses, 13, (1997), 1421. 
[45] S. Yang, R. Delgado, S. R. King, C. Woffendin, C. S. Barker, Z. Y. Yang, 
L. Xu, G. P. Nolan, G. J. Nabel, Hum. Gene Ther., 10, (1999), 123. 
[46] A. A. Bukovsky, J. P. Song, L. Naldini, J. Virol., 73, (1999), 7087. 
[47] J. P. Burand, M. D. Summers, G. E. Smith, Virology, 101, (1980), 286. 
[48] J. Weyermann, D. Lochmann, A. Zimmer, J. Contr. Release, 100, (2004), 
411. 
[49] M. R. Capecchi, Cell, 22, (1980), 479. 
[50] T. Masuda, H. Akita, H. Harashima, FEBS Lett., 579, (2005), 2143. 
[51] G. L. Andreason, G. A. Evans, Anal. Biochem., 180, (1989), 269. 
Anna Kovtun, Dissertation 2009 
 
125 
 
[52] H. Aihara, J. Miyazaki, Nat. Biotechnol., 16, (1998), 867. 
[53] E. Neumann, M. Schaefer-Ridder, Y. Wang, P. H. Hofschneider, EMBO 
J., 1, (1982), 841. 
[54] A. Fasbender, J. Zabner, B. G. Zeiher, M. J. Welsh, Gene Ther., 4, (1997), 
1173. 
[55] M. Junghans, S. M. Loitsch, S. C. Steiniger, J. Kreuter, A. Zimmer, Eur. 
J. Pharm. Biopharm., 60, (2005), 287. 
[56] H. T. Lv, S. B. Zhang, B. Wang, S. H. Cui, J. Yan, J. Contr. Release, 114, 
(2006), 100. 
[57] S. E. McNeil, Y. Perrie, Expert Opin. Ther. Pat., 16, (2006), 1371. 
[58] J. Zabner, A. J. Fasbender, T. Moninger, J. Biol. Chem., 270, (1995), 
18997. 
[59] J. Kunisawa, T. Masuda, K. Katayama, T. Yoshikawa, Y. Tsutsumi, M. 
Akashi, T. Mayumi, S. Nakagawa, J. Contr. Release, 105, (2005), 344. 
[60] D. D. Lasic, N. S. Templeton, Adv. Drug Deliv. Rev., 20, (1996), 221. 
[61] X. Zhou, L. Huang, Biochim. Biophys. Acta, 1189, (1994), 195. 
[62] R. I. Mahato, K. Kawabata, Y. Takakura, M. Hashida, J. Drug Target., 3, 
(1995), 149. 
[63] A. Swami, R. K. Kurupati, A. Pathak, J. Singh, P. Kumar, K. C. Gupta, 
Biochem. Biophys. Res. Comm., 362, (2007), 835. 
[64] A. N. Zelikin, Q. Li, F. Caruso, Angew. Chem., 118, (2006), 7907. 
[65] X. Zhu, L. Lu, B. L. Currier, A. J. Windebank, M. J. Yaszemski, 
Biomaterials, 23, (2002), 2683. 
[66] D. Lochmann, Dissertation, Goethe-Universität Frankfurt am Main, 
Frankfurt am Main, (2004). 
[67] D. Lochmann, J. Weyermann, C. Georgens, R. Prassl, A. Zimmer, Eur. J. 
Pharm. Biopharm., 59, (2005), 419. 
Anna Kovtun, Dissertation 2009 
 
126 
 
[68] J. Weyermann, D. Lochmann, C. Georgens, A. Zimmer, Eur. J. Pharm. 
Biopharm., 59, (2005), 431. 
[69] V. Vogel, D. Lochmann, J. Weyermann, G. Mayer, C. Tziatzios, J. A. van 
der Broek, W. Haase, D. Wouters, U. S. Schubert, J. Kreuter, A. Zimmer, 
D. Schubert, J. Contr. Release, 103, (2005), 99. 
[70] I. Puebla, S. Esseghir, A. Mortlock, A. Brown, A. Crisanti, W. Low, J. 
Biotechnol., 105, (2003), 215. 
[71] M. Tsoli, H. Kuhn, W. Brandau, H. Esche, G. Schmid, Small, 1, (2005), 
841. 
[72] R. Jin, G. Wu, Z. Li, C. A. Mirkin, G. C. Schatz, J. Am. Chem. Soc., 125, 
(2003), 1643. 
[73] N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. 
Han, C. A. Mirkin, Science, 312, (2006), 1027. 
[74] M. Thomas, A. M. Klibanov, Proc. Natl. Acad. Sci. USA, 100, (2003), 
9138. 
[75] J. Zhang, J. Malicka, I. Gryczynski, J. R. Lakowicz, Anal. Biochem., 330, 
(2004), 81. 
[76] A. A. Zinchenko, K. Yoshikawa, D. Baigl, Adv. Mater., 17, (2005), 2820. 
[77] A. Campo, T. Sen, J.-P. Lellouche, I. J. Bruce, J. Magn. Magn. Mater., 
293, (2005), 33. 
[78] A. Jordan, R. Scholz, P. Wust, H. Schirra, T. Schiestel, H. Schmidt, R. 
Felix, J. Magn. Magn. Mater., 194, (1999), 185. 
[79] X. M. Lin, A. C. S. Samia, J. Magn. Magn. Mater., 305, (2006), 100. 
[80] M. Boissièrea, J. Allouchea, C. Chanéaca, R. Braynerb, J. M. 
Devoissellec, J. Livagea, T. Coradin, Int. J. Pharm., 344, (2007), 128. 
[81] Z. Liu, M. Winters, M. Holodniy, H. Dai, Angew. Chem. Int. Ed., 46, 
(2007), 2023  
[82] G. Bhakta, S. Mitra, A. Maitra, Biomaterials, 26, (2005), 2157. 
Anna Kovtun, Dissertation 2009 
 
127 
 
[83] F. L. Graham, A. J. van der Eb, Virology, 52, (1973), 456. 
[84] S. V. Dorozhkin, M. Epple, Angew. Chem. Int. Ed., 41, (2002), 3130. 
[85] F. Neues, W. H. Arnold, J. Fischer, F. Beckmann, P. Gängler, M. Epple, 
Mat.-wiss. u. Werkstofftech., 37, (2006), 426. 
[86] P. Girard, L. Porte, T. Berta, M. Jordan, F. Wurm, Cytotechnology, 35, 
(2001), 175. 
[87] S. Chenuet, D. Martinet, N. Besuchet-Schmutz, M. Wicht, N. Jaccard, A. 
C. Bon, M. Derouazi, D. L. Hacker, J. S. Beckmann, F. Wurm, 
Biotechnol. Bioeng., 101, (2008), 937  
[88] S. Y. Watanabe, A. M. Albsoul-Younes, T. Kawano, H. Itoh, Y. Kaziro, 
S. Nakajima, Y. Nakajima, Neurosci. Res., 33, (1999), 71. 
[89] I. Segura, M. A. Gonzalez, A. Serrano, J. L. Abad, A. Bernad, H. H. 
Riese, Anal. Biochem., 296, (2001), 143. 
[90] A. Watson, D. Latchman, Methods, 10, (1996), 289. 
[91] V. Sokolova, Dissertation, Universität Duisburg-Essen, Essen, (2006). 
[92] A. Maitra, Expert. Rev. Mol. Diagn., 5, (2005), 893. 
[93] M. Jordan, A. Schallhorn, F. M. Wurm, Nucl. Acids Res., 24, (1996), 596. 
[94] M. Jordan, F. Wurm, Methods, 33, (2004), 136. 
[95] V. Sokolova, A. Kovtun, O. Prymak, W. Meyer-Zaika, E. A. Kubareva, E. 
A. Romanova, T. S. Oretskaya, R. Heumann, M. Epple, J. Mater. Chem., 
17, (2007), 721. 
[96] S. Bisht, G. Bhakta, S. Mitra, A. Maitra, Int. J. Pharm., 288, (2005), 157. 
[97] H. Fu, Y. Hu, T. McNelis, J. O. Hollinger, J. Biomed. Mater. Res., 74, 
(2005), 40. 
[98] D. Olton, J. Li, M. E. Wilson, T. Rogers, J. Close, L. Huang, N. P. Kumta, 
C. Sfeir, Biomaterials, 28, (2007), 1267. 
[99] V. Sokolova, O. Prymak, W. Meyer-Zaika, H. Cölfen, H. Rehage, A. 
Shukla, M. Epple, Mat.-wiss. u. Werkstofftech., 37, (2006), 441. 
Anna Kovtun, Dissertation 2009 
 
128 
 
[100] V. V. Sokolova, I. Radtke, R. Heumann, M. Epple, Biomaterials, 27, 
(2006), 3147. 
[101] F. Caruso, Colloids and Colloid Assemblies, Wiley-VCH, Weinheim, 
(2004). 
[102] Z. Adamczyk, P. Weronski, Adv. Colloid Interface Sci., 83, (1999), 137. 
[103] R. J. Hunter, Foundations of colloid science, Clarendon Press, Oxford, 
(1986). 
[104] D. H. Everett, Basic Principles of Colloid Science, Royal Society of 
Chemistry, London, (1988). 
[105] R. J. Hunter, Zeta potential in colloid science, Academic Press, (1988). 
[106] A. E. Ewence, M. Bootman, H. L. Roderick, J. N. Skepper, G. McCarthy, 
M. Epple, M. Neumann, C. M. Shanahan, D. Proudfoot, Circ. Res., 103, 
(2008), e28. 
[107] A. Doat, P. F., N. Gardant, A. Lebugle, J. Solid State Chem., 177, (2004), 
1179. 
[108] A. Doat, M. Fanjul, F. Pelle, E. Hollande, A. Lebugle, Biomaterials, 24, 
(2003), 3365. 
[109] S. Padilla Mondejar, A. Kovtun, M. Epple, J. Mater. Chem., 17, (2007), 
4153. 
[110] Y. Guo, D. Shi, J. Lian, Z. Dong, W. Wang, H. Cho, G. Liu, L. Wang, R. 
C. Ewing, Nanotechnology, 19, (2008), 175102. 
[111] R. Ramachandran, W. Paul, C. P. Sharma, J. Biomed. Mater. Res. B Appl. 
Biomater., 88, (2009), 41. 
[112] X. Cheng, L. Kuhn, Int. J. Nanomed., 2, (2007), 667. 
[113] B. Palazzo, M. Iafisco, M. Laforgia, N. Margiotta, G. Natile, C. L. 
Bianchi, D. Walsh, S. Mann, N. Roveri, Adv. Funct. Mater., 17, (2007), 
2180. 
Anna Kovtun, Dissertation 2009 
 
129 
 
[114] M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, 
E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-
Velasco, J. H. Adair, Nano Lett., 8, (2008), 4116. 
[115] T. T. Morgan, H. S. Muddana, E. I. Altinoglu, S. M. Rouse, A. 
Tabaković, T. Tabouillot, T. J. Russin, S. S. Shanmugavelandy, P. J. 
Butler, P. C. Eklund, J. K. Yun, M. Kester, J. H. Adair, Nano Lett., 8, 
(2008), 4108. 
[116] T. Welzel, W. Meyer-Zaika, M. Epple, Chem. Commun., (2004), 1204. 
[117] M. C. F. Magalhaes, P. A. A. P. Marques, R. N. Correia, in 
Biomineralization: Medical aspects of solubility, Calcium and magnesium 
phosphates: Normal and pathological mineralization, Wiley & Sons, 
(2006), 71. 
[118] C. Exley, J. D. Birchall, J. Theor. Biol., 159, (1992), 83. 
[119] E. H. Chowdhury, M. Kunou, M. Nagaoka, A. K. Kundu, T. Hoshiba, T. 
Akaike, Gene, 341, (2004), 77. 
[120] E. H. Chowdhury, F. T. Zohra, S. Tada, C. Kitamura, T. Akaike, Anal. 
Biochem., 335, (2004), 162. 
[121] A. Kovtun, Diploma thesis, University of Duisburg-Essen, Essen, (2006). 
[122] A. Kovtun, R. Heumann, M. Epple, Biomed. Mater. Eng., 19, (2009), 241. 
[123] T. Welzel, I. Radtke, W. Meyer-Zaika, R. Heumann, M. Epple, J. Mater. 
Chem., 14, (2004), 2213. 
[124] M. Nakanishi, T. Akuta, E. Nagoshi, A. Eguchi, H. Mizuguchi, T. Senda, 
Eur. J. Pharm. Sci., 13, (2001), 17. 
[125] A. Loyter, G. Scangos, D. Juricek, D. Keene, F. H. Ruddle, Exp. Cell 
Res., 139, (1982), 223. 
[126] V. Sokolova, A. Kovtun, R. Heumann, M. Epple, J. Biol. Inorg. Chem., 
12, (2007), 174. 
Anna Kovtun, Dissertation 2009 
 
130 
 
[127] Z. P. Xu, Q. H. Zeng, G. Q. Lu, A. B. Yu, Chem. Eng. Sci., 61, (2006), 
1027. 
[128] C. E. Pedraza, D. C. Basset, M. D. McKee, V. Nelea, U. Gbureck, J. E. 
Barralet, Biomaterials, 29, (2008), 3384. 
[129] T. Welzel, Diplomarbeit, Universität Duisburg-Essen, Essen, (2004). 
[130] S. G. Oakes, W. J. Martin, C. A. Lisek, G. Powis, Anal. Biochem., 169, 
(1988), 159. 
[131] K. Billing-Marczak, M. Przybyszewska, J. Kuznicki, Biochim. Biophys. 
Acta, 1449, (1999), 169. 
[132] W. Almers, E. Neher, FEBS Lett., 192, (1985), 13. 
[133] G. Grynkiewicz, M. Poenie, R. Y. Tsien, J. Biol. Chem., 260, (1985), 
3440. 
[134] J. Suh, D. Wirtz, J. Hanes, Proc. Natl. Acad. Sci. USA, 100, (2003), 3878. 
[135] J. Suh, D. Wirtz, J. Hanes, Biotechnol. Prog., 20, (2004), 598. 
[136] R. P. Kulkarni, D. D. Wu, M. E. Davis, S. E. Fraser, Proc. Natl. Acad. 
Sci. USA, 102, (2005), 7523. 
[137] M. P. Mattson, S. L. Chan, Nat. Cell Biol., 5, (2003), 1041. 
[138] D. J. McConkey, S. Orrenius, Biochem. Biophys. Res. Comm., 239, 
(1997), 357. 
[139] N. J. Caplen, S. Parrish, F. Imani, A. Fire, R. A. Morgan, Proc. Natl. 
Acad. Sci. USA, 98, (2001), 9742. 
[140] P. Sazani, A. Astriab-Fischer, R. Kole, Antisense Nucleic Acid Drug Dev., 
13, (2003), 119. 
[141] S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T. 
Tuschl, Nature, 411, (2001), 494. 
[142] S. M. Elbashir, W. Lendeckel, T. Tuschl, Genes Dev., 15, (2001). 
[143] T. J. Davidson, S. Harel, V. A. Arboleda, G. F. Prunell, M. L. Shelanski, 
L. A. Green, C. M. Troy, J. Neurosci., 24, (2004), 10040. 
Anna Kovtun, Dissertation 2009 
 
131 
 
[144] O. Donzé, D. Picard, Nucleic Acids Res., 30, (2002), e46. 
[145] C. D. Kaufman, Z. Izsvak, A. Katzer, Z. Ivics, J. RNAi Gene Silencing, 1, 
(2005), 97. 
[146] J. Schwiertz, W. Meyer-Zaika, L. Ruiz-Gonzalez, J. M. Gonzales-Calbet, 
M. Vallet-Regi, M. Epple, J. Mater. Chem., 18, (2008), 3831. 
[147] N. Jessel, M. Oulad-Abdelghani, F. Meyer, P. Lavalle, Y. Haikel, P. 
Schaaf, J.-C. Voegel, Proc. Natl. Acad. Sci. USA, 103, (2006), 8618. 
[148] J. Méndez Garza, N. Jessel, G. Ladam, V. Dupray, S. Muller, J.-F. Stoltz, 
P. Schaaf, J.-C. Voegel, P. Lavalle, Langmuir, 21, (2005), 12372. 
[149] X. Zhang, K. Sharma, M. Boeglin, J. Ogier, D. Mainard, J.-C. Voegel, Y. 
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7 Appendix 
7.1 List of abbreviations 
A adenine 
bp base pair 
BSA bovine serum albumin 
C cytosine 
CaP calcium phosphate 
C. elegans Caenorhabditis elegans 
CpG cytosin-phosphatidyl-guanosin 
DAPI 4',6-diamidino-2-phenylindole 
DC dendritic cells 
DLS dynamic light scattering 
DLVO Derjaguin, Landau, Verwey, Overbeek 
DMEM Dulbecco„s modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
ds double stranded 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetate 
EGFP enhanced green fluorescent protein 
FACS fluorescence-activated cell sorting 
FCS fetal calf serum 
FSC forward scatter 
G guanine 
G418 Geneticin 
HA hydroxyapatite 
HBS HEPES buffered solution 
HeLa Henrietta Lacks 
HEPES 4-2-hydroxyethyl-1-piperazineethanesulfonic acid 
HOb human osteoblasts 
IL interleukin 
kDa kilodalton 
LB Luria Bertani 
mRNA messenger RNA 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide 
miRNA microRNA 
nm nanometer 
NIH3T3 mouse embryonic fibroblast cell line 
NP nanoparticle 
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nt nucleotide 
PBS phosphate buffered saline 
PDI polydispersity index 
PEG poly(ethylene glycol) 
PGLA poly(lactide-co-glycolic acid) 
PI propidium iodide 
PLL poly-L-lysine 
PMSF phenylmethylsulphonyl fluoride 
Poly(I:C) poly(inosinic acid)-poly(cytidilic acid) 
RISC RNA induced silencing complex 
RNA ribonucleic acid 
RNAi RNA interference 
rRNA ribosomal RNA 
SD standard deviation 
SDS sodium dodecyl sulfate 
SEM scanning electron microscopy 
siRNA small interfering RNA 
shRNA short hairpin RNA 
SSC side scatter 
T thymine 
T24 human bladder carcinoma cells 
TRITC tetramethylrhodamine isothiocyanate 
TEM transmission electron microscopy 
tRNA transfer RNA 
U uracil 
UV ultraviolet 
WB Western Blotting 
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paste of calcium phosphate nanorods, functionalized with nucleic acids, 
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"Functionalisation of calcium phosphate nanoparticles by 
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3. A. Kovtun, V. Sokolova, R. Heumann, M. Epple "Mehrschalige 
Calciumphosphat-Nanopartikel als biokompatible Träger für 
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7.3 Presentations and posters 
1. 9th Essen Symposium Biomaterials and Biomechanics: Fundamentals and 
Clinical Applications, Essen, 05.-08.09.2006, V. Sokolova, A. Kovtun, O. 
Prymak, W. Meyer-Zaika, E.A. Kubareva, E.A. Romanova, T.S. Oretskaya, 
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Heumann, M. Epple, "Calcium phosphate nanoparticles as carriers of nucleic 
acids" (oral presentation). 
20. Jahrestagung der Deutschen Gesellschaft für Biomaterialien e.V. DGBM, 
Hamburg, 20.-22.11.2008, A. Kovtun, H. Urch, M. Neumeier, S. Neumann,  
R. Heumann, M. Köller, M. Epple,  "Transfizierende Metalloberflächen" 
(oral presentation). 
21. 11th International and Interdisciplinary Symposium "Biomaterials and 
Biomechanics: Fundamentals and Clinical Applications 2009", 5.-7.03.2009, 
Essen, S. Neumann, A. Kovtun, I. D. Dietzel-Meyer, M. Epple, R. Heumann, 
"Size-defined calcium phosphate nanoparticles serve as a superior tool for 
cellular DNA transfection: Absence of intracellular Ca
2+
 disturbance"  (oral 
presentation). 
22. 60. Mosbacher Kolloquium "Molecular and Cellular Mechanisms of 
Memory”, Mosbach/Baden, Germany, 19.-21.03.2009, S. Neumann, A. 
Kovtun, I. Dietzel-Meyer, M. Epple, R. Heumann, "Cellular transfection with 
DNA-functionalised calcium phosphate nanoparticles circumvents 
disturbance of intracellular calcium levels" (poster). 
23. 2009 MRS Spring Meeting, San Francisco, USA, 13.-17.04.2009, A. Kovtun, 
S. Neumann, M. Neumeier, H. Urch, R. Heumann, M. Köller, M. Epple, 
"Nanoparticle-madiated gene transfer from metal surfaces" (poster). 
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and Biology, Neuhardenberg, 01.-03.06.2009, K. Ganesan, A. Kovtun, S. 
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functionalized porphyrin" (oral presentation). 
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calcium phosphate/DNA nanoparticles" (poster).  
26. 22nd European Conference on Biomaterials, Lausanne, Switzerland, 08.-
12.09.2009, A. Kovtun, S. Neumann, M. Neumeier, H. Urch, R. Heumann, 
M. Köller, M. Epple, "Local gene transfer from nanoparticle-loaded titanium 
surfaces" (oral presentation). 
27. 11th International Conference on Advanced Materials (ICAM 2009), Rio de 
Janeiro, Brazil, 20.-25.09.2009, A. Kovtun, S. Neumann, R. Heumann, M. 
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gene transfer" (oral presentation). 
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Hamburg, M. Epple, A. Kovtun, V. Sokolova, J. Klesing, M. Neumeier, S. 
Neumann, R. Heumann, "Colloidal stability of calcium phosphate 
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